KR20210152189A - Oxime ester carbazole compound,and photosensitive resin composition containing thereof - Google Patents

Oxime ester carbazole compound,and photosensitive resin composition containing thereof Download PDF

Info

Publication number
KR20210152189A
KR20210152189A KR1020200068963A KR20200068963A KR20210152189A KR 20210152189 A KR20210152189 A KR 20210152189A KR 1020200068963 A KR1020200068963 A KR 1020200068963A KR 20200068963 A KR20200068963 A KR 20200068963A KR 20210152189 A KR20210152189 A KR 20210152189A
Authority
KR
South Korea
Prior art keywords
formula
compound
oxime ester
resin composition
photosensitive resin
Prior art date
Application number
KR1020200068963A
Other languages
Korean (ko)
Other versions
KR102397593B1 (en
Inventor
이정원
정인
이상은
Original Assignee
인오켐 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 인오켐 주식회사 filed Critical 인오켐 주식회사
Priority to KR1020200068963A priority Critical patent/KR102397593B1/en
Publication of KR20210152189A publication Critical patent/KR20210152189A/en
Application granted granted Critical
Publication of KR102397593B1 publication Critical patent/KR102397593B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/86Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/34Heterocyclic compounds having nitrogen in the ring
    • C08K5/3412Heterocyclic compounds having nitrogen in the ring having one nitrogen atom in the ring
    • C08K5/3415Five-membered rings
    • C08K5/3417Five-membered rings condensed with carbocyclic rings
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/027Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • G03F7/028Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with photosensitivity-increasing substances, e.g. photoinitiators
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03FPHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
    • G03F7/00Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
    • G03F7/004Photosensitive materials
    • G03F7/027Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
    • G03F7/032Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with binders
    • G03F7/033Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds with binders the binders being polymers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. vinyl polymers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Indole Compounds (AREA)

Abstract

The present invention provides an oxime ester carbazole compound represented by chemical formula 1 or chemical formula 2, wherein in the chemical formulas: X is Cl or Br; R_1 and R_3 are each independently C_1 to C_20 alkyl, C_5 to C_10 cycloalkyl, C_6 to C_30 aryloxy, C_1 to C_20 alkylthio, C_6 to C_30 aryl, C_7 to C_30 aralkyl, or C_5 to C_30 heteroaryl; R_2 is C_1 to C_3 alkyl or phenyl; and n is an integer from 1 to 3.

Description

옥심에스테르 카르바졸 화합물 및 이를 포함하는 감광성 수지{OXIME ESTER CARBAZOLE COMPOUND,AND PHOTOSENSITIVE RESIN COMPOSITION CONTAINING THEREOF}Oxime ester carbazole compound and photosensitive resin comprising the same

본 발명은 옥심에스테르 카르바졸 화합물 및 이를 포함하는 감광성 수지 조성물에 관한 것이다. 보다 구체적으로 유기 용제에 대한 우수한 용해성을 가지는 옥심에스테르 카르바졸 화합물, 이를 포함하는 감광성 수지 조성물에 관한 것이다. The present invention relates to an oxime ester carbazole compound and a photosensitive resin composition comprising the same. More specifically, it relates to an oxime ester carbazole compound having excellent solubility in organic solvents, and a photosensitive resin composition comprising the same.

광개시제는 빛을 흡수하여 분해됨으로써 화학적으로 활성을 지닌 원자 또는 분자를 생성하는 물질이며, 감광성 조성물 등에 널리 사용된다.A photoinitiator is a substance that absorbs light and decomposes to generate chemically active atoms or molecules, and is widely used in photosensitive compositions and the like.

화학적 활성을 지닌 물질의 예로는 산이나 염기 그리고 라디칼 등이 있다. 특히, 라디칼이 생성되는 광개시제는 라디칼과 함께 중합 반응을 일으키는 아크릴기와 함께 사용되어 코팅된 막의 강도를 향상시키는 목적으로 사용될 수 있다.Examples of chemically active substances include acids, bases, and radicals. In particular, the photoinitiator in which radicals are generated may be used together with an acryl group that causes a polymerization reaction with the radical to improve the strength of the coated film.

이러한 용도의 감광성 조성물로는 잉크젯용 잉크 또는 자동차나 휴대폰 등의 투명하거나 착색된 보호막 등이 있으며 빛에 의한 중합 반응에 따른 용해도가 감소되는 현상을 이용하는 광식각법용 감광성 수지 조성물에 광개시제가 응용될 수 있다.The photosensitive composition for this purpose includes ink for inkjet ink or a transparent or colored protective film for automobiles or mobile phones, etc., and a photoinitiator can be applied to the photosensitive resin composition for photolithography using a phenomenon in which solubility is reduced due to polymerization by light. have.

대표적인 예로는 액정표시소자의 컬러 필터 제조에 사용되는 광중합형 감광성 수지 조성물이나, 수지 블랙 매트릭스용 감광성 조성물 등이 있다. 감광성 조성물은 기판상에 도포되어 도막을 형성하고, 이 도막의 특정 부분에 포토마스크 등을 이용하여 광조사에 의한 노광을 실시한 후, 비노광부를 현상처리하여 제거함으로써 패턴을 형성하는데 사용될 수 있다.Representative examples include a photopolymerization type photosensitive resin composition used for manufacturing a color filter of a liquid crystal display device, a photosensitive composition for a resin black matrix, and the like. The photosensitive composition may be applied on a substrate to form a coating film, exposed by light irradiation using a photomask or the like on a specific portion of the coating film, and then developed and removed to form a pattern.

감광성 수지 조성물은 통상적으로 고분자 수지 화합물과 에틸렌성 불포화 결합을 포함하는 중합성 화합물, 용매, 그리고 광개시제를 포함한다.The photosensitive resin composition typically includes a polymeric resin compound, a polymerizable compound containing an ethylenically unsaturated bond, a solvent, and a photoinitiator.

감광성 수지 조성물은 LCD의 용도가 고급화, 다양화됨에 따라 종래의 노트북, 모바일 등의 용도 외에 TV, 모니터 등의 액정표시소자를 구성하는 용도로 제작되고 있으며, 생산성 및 내구성 향상을 위해 빛에 빠르게 반응하고, 기계적으로 우수한 물성에 대한 요구가 높아지고 있다.The photosensitive resin composition is being manufactured for the purpose of composing liquid crystal display devices such as TVs and monitors in addition to the conventional use of laptops and mobiles as the uses of LCDs are advanced and diversified, and reacts quickly to light to improve productivity and durability. And, the demand for mechanically excellent physical properties is increasing.

한편 포토리소그래피(Photo-lithography) 법에 의해 패턴을 형성시키거나, 전면 노광을 통해 절연 보호막을 형성하는 경우에 있어 빛에 빠르게 반응하는 특성, 즉 광감도는 매우 중요한 역할을 하는 요인이 된다. 또한, 외부에서 가한 충격에 의해 액정표시소자가 파손되지 않고 원래의 성능을 발휘하게 하기 위해서 지지대 역할을 하는 컬럼 스페이서 또는 보호막의 역할을 하는 오버코트와 패시베이션 막은 기계적 물성이 우수해야 한다. 따라서, 광감도가 우수한 광중합 개시제를 사용하면 이러한 문제들을 해결할 수 있다.On the other hand, when a pattern is formed by a photo-lithography method or an insulating protective film is formed through full exposure, the property of quickly responding to light, that is, photosensitivity, is a very important factor. In addition, in order to ensure that the liquid crystal display device is not damaged by an external impact and exhibits its original performance, the column spacer serving as a support or an overcoat and passivation film serving as a protective film must have excellent mechanical properties. Accordingly, these problems can be solved by using a photopolymerization initiator having excellent photosensitivity.

감광성 수지 조성물에 사용되는 광개시제의 일반적인 예는 아세토페논 유도체, 벤조페논 유도체, 트리아진 유도체, 비이미다졸 유도체, 아실포스핀 옥사이드 유도체 및 옥심에스테르 유도체 등 여러 종류가 알려져 있으며, 이중 옥심에스테르 유도체는 자외선을 흡수하여 색을 거의 나타내지 않고, 라디칼 발생 효율이 높으며, 감광성수지 조성물 재료들과의 상용성 및 안정성이 우수한 장점을 갖고 있다.Common examples of photoinitiators used in the photosensitive resin composition include acetophenone derivatives, benzophenone derivatives, triazine derivatives, biimidazole derivatives, acylphosphine oxide derivatives, and oxime ester derivatives. It absorbs and exhibits almost no color, has a high radical generation efficiency, and has excellent compatibility and stability with the materials of the photosensitive resin composition.

그러나 초기에 개발된 옥심에스테르 유도체 화합물은 광중합 개시 효율이 낮으며, 특히 패턴 노광 공정 시 감도가 낮아 노광량을 늘려야 하고 이로 인해 생산량이 줄어드는 문제가 있다.However, the initially developed oxime ester derivative compound has a low photopolymerization initiation efficiency, and, in particular, has a low sensitivity during a pattern exposure process, so that an exposure amount needs to be increased, thereby reducing production.

최근에 대면적 고화질 디스플레이의 수요가 증가하면서 해상도를 높이기 위해 미세패턴 특성이 요구됨에 따라 고감도 및 유기 용제에 대한 용해성이 우수한 광개시제를 포함하는 감광성 조성물에 대한 요구가 증가하고 있다.Recently, as the demand for large-area high-definition displays increases and fine pattern characteristics are required to increase resolution, there is an increasing demand for a photosensitive composition including a photoinitiator having high sensitivity and excellent solubility in organic solvents.

대한민국 특허공개공보 제10-2008-0109833호는 감광성 조성물, 감광성 필름, 감광성 적층재, 영구 패턴 형성 방법, 및 프린트 기판에 관한 것으로 옥심에스테르 유도체와 특정 증감제를 사용하는 감광성 조성물을 개시하고 있으나, 용해도가 낮고 감도가 낮아서 충분한 생산성 향상을 기대하기 어렵다.Korean Patent Laid-Open Publication No. 10-2008-0109833 discloses a photosensitive composition using an oxime ester derivative and a specific sensitizer, which relates to a photosensitive composition, a photosensitive film, a photosensitive laminate, a method for forming a permanent pattern, and a printed board. It is difficult to expect sufficient productivity improvement due to low solubility and low sensitivity.

본 발명의 목적은 유기 용제에 대한 용해성이 증가되고, 광중합 개시 효율이 증가되어 광감도가 증가된 옥심에스테르 카르바졸 화합물과, 이를 포함하는 감광성 수지 조성물을 제공하기 위한 것이다. It is an object of the present invention to provide an oxime ester carbazole compound with increased photosensitivity due to increased solubility in organic solvents and increased photopolymerization initiation efficiency, and a photosensitive resin composition comprising the same.

본 발명의 상기 및 기타의 목적들은 하기 설명되는 본 발명에 의하여 모두 달성될 수 있다.The above and other objects of the present invention can all be achieved by the present invention described below.

1. 본 발명의 하나의 관점은 옥심에스테르 카르바졸 화합물에 관한 것이다. 1. One aspect of the present invention relates to an oximeester carbazole compound.

상기 옥심에스테르 카르바졸 화합물은 하기 화학식 1 또는 화학식 2로 표시된다: The oxime ester carbazole compound is represented by Formula 1 or Formula 2:

[화학식 1][Formula 1]

Figure pat00001
Figure pat00001

[화학식 2][Formula 2]

Figure pat00002
Figure pat00002

여기서, X는 Cl 또는 Br이고, R1 과 R3 는 각각 독립적으로 C1 내지 C20 알킬, C5 내지 C10 시클로알킬, C6 내지 C30 아릴옥시, C1 내지 C20 알킬티오, C6 내지 C30 아릴, C7 내지 C30 아르알킬, 또는 C5 내지 C30 헤테로아릴이며, R2 는 C1 내지 C3 알킬 또는 페닐이고, wherein X is Cl or Br, R 1 and R 3 are each independently C 1 to C 20 alkyl, C 5 to C 10 cycloalkyl, C 6 to C 30 aryloxy, C 1 to C 20 alkylthio, C 6 to C 30 aryl, C 7 to C 30 aralkyl, or C 5 to C 30 heteroaryl, R 2 is C 1 to C 3 alkyl or phenyl;

n은 1 내지 3의 정수이다. n is an integer from 1 to 3.

2. 상기 1 구체예에서, X는 Cl이고, R1 과 R3 는 각각 독립적으로 직쇄 또는 분기쇄인 C1 내지 C20 알킬, C5 내지 C10 시클로알킬, C6 내지 C30 아릴이고, R2 는 메틸 또는 페닐일 수 있다. 2. In the above 1 embodiment, X is Cl, R 1 and R 3 are each independently linear or branched C 1 to C 20 alkyl, C 5 to C 10 cycloalkyl, C 6 to C 30 aryl, R 2 may be methyl or phenyl.

3. 상기 1 또는 2 구체예에서, 상기 화학식 1의 화합물은 하기 화학식 1-1 내지 1-30 중 선택되는 어느 하나일 수 있다. 3. In embodiments 1 or 2, the compound of Formula 1 may be any one selected from Formulas 1-1 to 1-30.

Figure pat00003
Figure pat00003

Figure pat00004
Figure pat00004

Figure pat00005
Figure pat00005

4. 상기 1 내지 3 구체예에서, 상기 화학식 2의 화합물은 하기 화학식 2-1 내지 2-24 중 선택되는 어느 하나일 수 있다. 4. In embodiments 1 to 3, the compound of Formula 2 may be any one selected from the following Formulas 2-1 to 2-24.

Figure pat00006
Figure pat00006

Figure pat00007
Figure pat00007

Figure pat00008
Figure pat00008

5. 본 발명의 다른 관점은 상기 옥심에스테르 카르바졸 화합물; 및 에틸렌계 불포화 결합을 가지는 화합물을 포함하는 감광성 수지 조성물을 제공한다. 5. Another aspect of the present invention is the oxime ester carbazole compound; And it provides a photosensitive resin composition comprising a compound having an ethylenically unsaturated bond.

6. 상기 5 구체예에서, 상기 감광성 수지 조성물은 현상성 바인더 수지를 더 포함할 수 있다. 6. In the 5th embodiment, the photosensitive resin composition may further include a developable binder resin.

7. 상기 5 또는 6 구체예에서, 상기 현상성 바인더 수지는 아크릴산함유 아크릴공중합체, 노볼락계 페놀수지, 폴리히드록시스트렌수지, 히드록시스티렌 및 아크릴레이트의 공중합체로 이루어진 군에서 선택된 어느 하나 또는 둘 이상의 혼합물일 수 있다. 7. In the above 5 or 6 embodiments, the developable binder resin is any one selected from the group consisting of acrylic acid-containing acrylic copolymer, novolak-based phenol resin, polyhydroxystyrene resin, hydroxystyrene and copolymer of acrylate. It may be one or a mixture of two or more.

본 발명은 적은 노광량으로도 라디칼 생성 효율이 우수한 광개시제를 제공하여 고감도를 가지는 감광성 수지 조성물을 제조할 수 있다. The present invention can prepare a photosensitive resin composition having high sensitivity by providing a photoinitiator having excellent radical generation efficiency even with a small exposure amount.

감광성 수지 조성물 제조 시 용제에 대하여 과량으로 첨가하는 경우에도 용해성이 증가되어 침전이 발생하지 않으므로 대형 LCD제조 공정 등의 효율을 매우 증가시킬 수 있다. Even when an excess of solvent is added to the photosensitive resin composition, solubility is increased and precipitation does not occur, so the efficiency of a large LCD manufacturing process can be greatly increased.

또한 감광성 수지 조성물은 니트로기로 치환된 카르바졸 고리 내 질소 원자에 에틸에테르기가 도입되고, 일단에 알킬 또는 아릴 치환되어 용제에 대한 용해성 증가될 뿐만 아니라 패턴안정성, 내화학성 및 밀착성이 증가된다. In addition, in the photosensitive resin composition, an ethyl ether group is introduced into a nitrogen atom in the carbazole ring substituted with a nitro group, and the solubility in a solvent is increased by being substituted with alkyl or aryl at one end, as well as pattern stability, chemical resistance and adhesion.

도 1은 본 발명의 한 구체예에 따른 감광성 수지 조성물의 감도 평가 그래프이다. 1 is a graph showing the sensitivity evaluation of a photosensitive resin composition according to an embodiment of the present invention.

명세서 전체에 걸쳐 동일 참조 부호는 동일 구성 요소를 지칭한다. 또한, 본 발명을 설명함에 있어서, 관련된 공지 기술에 대한 구체적인 설명이 본 발명의 요지를 불필요하게 흐릴 수 있다고 판단되는 경우 그 상세한 설명은 생략한다. Like reference numerals refer to like elements throughout. In addition, in describing the present invention, if it is determined that a detailed description of a related known technology may unnecessarily obscure the gist of the present invention, the detailed description thereof will be omitted.

본 명세서 상에서 언급한 '포함한다', '갖는다', '이루어진다' 등이 사용되는 경우 '~만'이 사용되지 않는 이상 다른 부분이 추가될 수 있다. 구성 요소를 단수로 표현한 경우에 특별히 명시적인 기재 사항이 없는 한 복수를 포함하는 경우를 포함한다.When 'including', 'having', 'consisting', etc. mentioned in this specification are used, other parts may be added unless 'only' is used. When a component is expressed in the singular, cases including the plural are included unless otherwise explicitly stated.

구성 요소를 해석함에 있어서, 별도의 명시적 기재가 없더라도 오차 범위를 포함하는 것으로 해석한다.In interpreting the components, it is construed as including an error range even if there is no separate explicit description.

본 발명의 하나의 관점은 하기 화학식 1 또는 화학식 2로 표시되는 옥심에스테르 카르바졸 화합물을 제공한다. One aspect of the present invention provides an oxime ester carbazole compound represented by the following Chemical Formula 1 or Chemical Formula 2.

[화학식 1][Formula 1]

Figure pat00009
Figure pat00009

[화학식 2][Formula 2]

Figure pat00010
Figure pat00010

여기서, X는 Cl 또는 Br이고, R1 과 R3 는 각각 독립적으로 C1 내지 C20 알킬, C5 내지 C10 시클로알킬, C6 내지 C30 아릴옥시, C1 내지 C20 알킬티오, C6 내지 C30 아릴, C7 내지 C30 아르알킬, 또는 C5 내지 C30 헤테로아릴이며, R2 는 C1 내지 C3 알킬 또는 페닐이고, wherein X is Cl or Br, R 1 and R 3 are each independently C 1 to C 20 alkyl, C 5 to C 10 cycloalkyl, C 6 to C 30 aryloxy, C 1 to C 20 alkylthio, C 6 to C 30 aryl, C 7 to C 30 aralkyl, or C 5 to C 30 heteroaryl, R 2 is C 1 to C 3 alkyl or phenyl;

n은 1 내지 3의 정수이다. n is an integer from 1 to 3.

보다 구체적으로 X는 Cl이고, R1 과 R3 는 각각 독립적으로 직쇄 또는 분기쇄인 C1 내지 C20 알킬, C5 내지 C10 시클로알킬, C6 내지 C30 아릴이고, R2 는 메틸 또는 페닐인 것이 바람직하다. More specifically, X is C 1 , R 1 and R 3 are each independently linear or branched C 1 to C 20 alkyl, C 5 to C 10 cycloalkyl, C 6 to C 30 aryl, and R 2 is methyl or phenyl.

상기 R1 과 R3 이 알킬 또는 아릴이고, R2 는 메틸 또는 페닐인 경우 감광성 수지 조성물에서 패턴안정성, 내화학성, 및 밀착성을 향상시킬 수 있다. When R 1 and R 3 are alkyl or aryl, and R 2 is methyl or phenyl, pattern stability, chemical resistance, and adhesion may be improved in the photosensitive resin composition.

상기 화학식 1 또는 화학식 2로 표시되는 옥심에스테르 카르바졸 화합물은 카르바졸 고리 내 질소 원자에 1 단위체 내지 3단위체인 에틸에스테르를 포함하는 2-할로 에틸에테르기를 도입하여 감광성 조성물의 용제로 유용한 프로필렌글리콜메틸에테르아세테이트(PGMEA)에 용해성이 크게 증가한다.The oxime ester carbazole compound represented by Formula 1 or Formula 2 introduces a 2-halo ethyl ether group containing an ethyl ester that is 1 to 3 units to a nitrogen atom in the carbazole ring. Propylene glycol methyl useful as a solvent for a photosensitive composition The solubility in ether acetate (PGMEA) is greatly increased.

한편, 상기 R1, R2 또는 R3이 각각 독립적으로 알킬인 경우, 상기 알킬은 메틸, 에틸, 프로필, 이소프로필, 부틸, 이소부틸, s-부틸, t-부틸, 아밀, 이소아밀, t-아밀, 헥실, 헵틸, 옥틸, 이소옥틸, 2-에틸헥실, 노닐, 데실, 운데실, 도데실, 테트라데실, 헥사데실, 옥타데실, 이코실, 시클로펜틸, 시클로헥실, 시클로헥실메틸, 비닐, 알릴, 부테닐, 에티닐, 및 프로피닐로 이루어진 군에서 선택된 어느 하나일 수 있다. On the other hand, when R 1 , R 2 or R 3 is each independently alkyl, the alkyl is methyl, ethyl, propyl, isopropyl, butyl, isobutyl, s-butyl, t-butyl, amyl, isoamyl, t -amyl, hexyl, heptyl, octyl, isooctyl, 2-ethylhexyl, nonyl, decyl, undecyl, dodecyl, tetradecyl, hexadecyl, octadecyl, icosyl, cyclopentyl, cyclohexyl, cyclohexylmethyl, vinyl , allyl, butenyl, ethynyl, and may be any one selected from the group consisting of propynyl.

또한 상기 R1, 또는 R3이 각각 독립적으로 아릴인 경우에는 페닐, p-메톡시페닐, o-하이드록시페닐, m-하이드록시페닐, p-하이드록시페닐, p-플루오로페닐, p-클로로페닐, p-브로모페닐, 펜타플루오로페닐, 비페닐, 1-나프틸, 2-나프틸, 9-안트릴, 9-페난톨릴, 1-피레닐, 9-플루오레닐, 터페닐기, o- 톨릴, m- 톨릴, p-톨릴, 및 크세닐로 이루어진 군에서 선택된 어느 하나인 것이 바람직하다. In addition, when R 1 , or R 3 is each independently aryl, phenyl, p-methoxyphenyl, o-hydroxyphenyl, m-hydroxyphenyl, p-hydroxyphenyl, p-fluorophenyl, p- Chlorophenyl, p-bromophenyl, pentafluorophenyl, biphenyl, 1-naphthyl, 2-naphthyl, 9-anthryl, 9-phenantholyl, 1-pyrenyl, 9-fluorenyl, terphenyl group , o-tolyl, m-tolyl, p-tolyl, and preferably any one selected from the group consisting of xenyl.

상기 R1, 또는 R3이 각각 독립적으로 아르알킬인 경우에는 벤질, 클로로벤질, α-메틸벤질, α,α -디메틸벤질, 페닐에틸, 및 페닐에테닐로 이루어진 군에서 선택된 어느 하나인 것이 바람직하다. When R 1 , or R 3 is each independently aralkyl, preferably any one selected from the group consisting of benzyl, chlorobenzyl, α-methylbenzyl, α,α-dimethylbenzyl, phenylethyl, and phenylethenyl do.

상기 R1, 또는 R3이 각각 독립적으로 헤테로아릴기인 경우에는 푸릴, 티에닐, 테트라히드로푸릴, 디옥솔라닐, 벤조옥사졸-2-일, 테트라히드로피라닐, 및 피롤리딜로 이루어진 군에서 선택된 어느 하나인 것이 바람직하다. When R 1 , or R 3 is each independently a heteroaryl group, from the group consisting of furyl, thienyl, tetrahydrofuryl, dioxolanyl, benzoxazol-2-yl, tetrahydropyranyl, and pyrrolidyl It is preferable that any one selected.

상기 R2가 알킬인 경우 메틸, 에틸 또는 프로필 등이며, 아릴기인 경우 페닐인 것이 바람직하다.When R 2 is an alkyl, it is methyl, ethyl, or propyl, and in the case of an aryl group, it is preferably phenyl.

보다 구체적으로 상기 화학식 1의 화합물은 하기 화학식 1-1 내지 1-30 중 선택되는 어느 하나이다. More specifically, the compound of Formula 1 is any one selected from the following Formulas 1-1 to 1-30.

Figure pat00011
Figure pat00011

Figure pat00012
Figure pat00012

Figure pat00013
Figure pat00013

또한 상기 화학식 2의 화합물은 하기 화학식 2-1 내지 2-24 중 선택되는 어느 하나이다. In addition, the compound of Formula 2 is any one selected from the following Formulas 2-1 to 2-24.

Figure pat00014
Figure pat00014

Figure pat00015
Figure pat00015

Figure pat00016
Figure pat00016

본 발명의 다른 관점은, 상기 옥심에스테르 카르바졸 화합물; 및 에틸렌계 불포화 결합을 가지는 화합물을 포함하는 감광성 수지 조성물을 제공한다. Another aspect of the present invention, the oxime ester carbazole compound; And it provides a photosensitive resin composition comprising a compound having an ethylenically unsaturated bond.

본 발명의 한 구체예에서 감광성 수지 조성물은 옥심에스테르 카르바졸 화합물 0.001 내지 10 wt%, 현상성 바인더 10 내지 50 wt%, 에틸렌계 불포화 결합을 가지는 화합물 5 내지 30 wt%, 및 용매 50 내지 80 wt%를 포함한다.In one embodiment of the present invention, the photosensitive resin composition comprises 0.001 to 10 wt% of an oxime ester carbazole compound, 10 to 50 wt% of a developable binder, 5 to 30 wt% of a compound having an ethylenically unsaturated bond, and 50 to 80 wt% of a solvent Including %.

상기 에틸렌계 불포화 결합을 가지는 화합물은 메틸(메타)아크릴레이트, 에틸(메타)아크릴레이트, 부틸(메타)아크릴레이트, 2-에틸헥실(메타)아크릴레이트, 라우릴(메타)아크릴레이트 등의 (메타)아크릴산의 알킬에스테르, 글리시딜(메타)아크릴레이트, 에틸렌옥사이드기의 수가 2 내지 14인 폴리에틸렌글리콜모노(메타)아크릴레이트, 에틸렌글리콜디(메타)아크릴레이트, 에틸렌 옥사이드기의 수가 2 내지 14인 폴리에틸렌글리콜디(메타)아크릴레이트, 프로필렌옥사이드기의 수가 2 내지 14인 프로필렌글리콜디(메타)아크릴레이트, 트리메틸올프로판디(메타) 아크릴레이트, 비스페놀 A 디글리시딜에테르아크릴산 부가물, β-히드록시 에틸(메타)아크릴레이트의 프탈산디에스테르, β -히드록시에틸(메타) 아크릴레이트의 톨루엔디이소시아네이트 부가물, 트리메틸올프로판트리(메타) 아크릴레이트, 펜타에리스리톨트리(메타)아크릴레이트, 펜타에리스리톨테트라(메타)아크릴레이트, 디펜타에리스리톨펜타(메타)아크릴레이트, 디펜타에리스리톨 헥사(메타)아크릴레이트, 디펜타에리스리톨트리(메타)아크릴레이트와 같이 다가 알콜과 α, β -불포화 카르복시산을 에스테르화하여 얻어지는 화합물, 및 트리메틸올프로판트리글리시딜에테르아크릴산 부가물과 같이 다가 글리시딜 화합물의 아크릴산 부가물로 이루어진 군에서 선택된 어느 하나 또는 2종 이상 함께 사용할 수 있다.The compound having the ethylenically unsaturated bond is (meth) acrylate, ethyl (meth) acrylate, butyl (meth) acrylate, 2-ethylhexyl (meth) acrylate, lauryl (meth) acrylate ( Alkyl ester of meth) acrylic acid, glycidyl (meth) acrylate, polyethylene glycol mono (meth) acrylate having 2 to 14 ethylene oxide groups, ethylene glycol di (meth) acrylate, ethylene oxide group 2 to 14 polyethylene glycol di (meth) acrylate, propylene glycol di (meth) acrylate having 2 to 14 propylene oxide groups, trimethylolpropane di (meth) acrylate, bisphenol A diglycidyl ether acrylic acid adduct; Phthalic acid diester of β-hydroxyethyl (meth) acrylate, toluene diisocyanate adduct of β-hydroxyethyl (meth) acrylate, trimethylolpropane tri (meth) acrylate, pentaerythritol tri (meth) acrylate , pentaerythritol tetra (meth) acrylate, dipentaerythritol penta (meth) acrylate, dipentaerythritol hexa (meth) acrylate, dipentaerythritol tri (meth) acrylate with polyhydric alcohols such as α, β-unsaturated carboxylic acids Any one or two or more selected from the group consisting of a compound obtained by esterifying a compound and an acrylic acid adduct of a polyvalent glycidyl compound such as trimethylolpropane triglycidyl ether acrylic acid adduct may be used together.

상기 종류의 에틸렌계 불포화 결합을 가지는 중합성 화합물은 상기 옥심에스테르 화합물과 혼합하는 경우 광개시제로 사용하기에 적합하다.The polymerizable compound having an ethylenically unsaturated bond of the above type is suitable for use as a photoinitiator when mixed with the oxime ester compound.

상기 중합성 화합물을 포함하는 경우에는 증가된 내열성, 막강도를 얻을 수 있으며, 감광성 수지 조성물의 현상성을 증가시킬 수 있다. When the polymerizable compound is included, increased heat resistance and film strength may be obtained, and developability of the photosensitive resin composition may be increased.

상기 중합성 화합물을 2종 이상 혼합하여 사용하는 경우에는 공중합하여 공중합체로 사용하는 것이 바람직하다. When two or more types of the above-mentioned polymerizable compound are mixed and used, it is preferable to use them as a copolymer by copolymerization.

상기 감광성 수지 조성물은 현상성 바인더 수지를 더 포함한다. The photosensitive resin composition further includes a developable binder resin.

상기 현상성 바인더 수지는 아크릴산함유 아크릴공중합체, 노볼락계 페놀수지, 폴리히드록시스트렌수지, 폴리실록산수지, 폴리이미드수지, 히드록시스티렌 및 아크릴레이트의 공중합체로 이루어진 군에서 선택된 어느 하나 또는 둘 이상의 혼합물일 수 있다. The developable binder resin is any one or two selected from the group consisting of acrylic acid-containing acrylic copolymer, novolak-based phenol resin, polyhydroxystyrene resin, polysiloxane resin, polyimide resin, hydroxystyrene, and a copolymer of acrylate. It may be a mixture of the above.

상기 현상성 바인더 수지는 불포화 일염기산으로 감광성 수지 조성물의 현상성을 증가시킬 수 있다. The developable binder resin may increase the developability of the photosensitive resin composition with an unsaturated monobasic acid.

이하, 본 발명의 이해를 돕기 위하여 바람직한 실시예를 제시하나, 하기 실시예는 본 발명을 예시하는 것일 뿐 본 발명의 범위가 하기 실시예에 한정되는 것은 아니다. 본 발명의 실시예는 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공하는 것이다.Hereinafter, preferred examples are presented to help the understanding of the present invention, but the following examples are only illustrative of the present invention and the scope of the present invention is not limited to the following examples. The embodiments of the present invention are provided to more completely explain the present invention to those of ordinary skill in the art.

[반응식 1][Scheme 1]

Figure pat00017
Figure pat00017

상기 반응식 1에 따라, 화학식 1-1 내지 1-30 화합물을 합성하였다. According to Scheme 1, compounds of Formulas 1-1 to 1-30 were synthesized.

염기 존재 하에 카르바졸과 다이할로 에틸에테르의 SN2 반응으로부터 준비된 2-할로 에틸에테르 카르바졸과 아실 클로라이드를 루이스산(Lewis acid) 존재 하에 Fridel-Craft 반응을 통해 상응하는 케톤 화합물을 얻었다. 2-halo ethyl ether carbazole and acyl chloride prepared from the S N 2 reaction of carbazole and dihalo ethyl ether in the presence of a base were subjected to Fridel-Craft reaction in the presence of Lewis acid to obtain the corresponding ketone compound.

상기 케톤 화합물을 질산과 반응시켜 카르바졸 고리에 니트로기를 도입하고 상기 니트로 케톤 화합물은 염산 하이드록실아민과 옥심 반응을 거쳐 상응하는 옥심 화합물을 얻었다. 상기 옥심 화합물을 아실 할라이드 또는 상응하는 언하이드라이드와 반응시켜 상기 화학식 1-1 내지 1-30로 표현되는 옥심에스테르 카르바졸 유도체 화합물들을 수득하였다. The ketone compound was reacted with nitric acid to introduce a nitro group to the carbazole ring, and the nitro ketone compound was subjected to an oxime reaction with hydroxylamine hydrochloride to obtain the corresponding oxime compound. The oxime compound was reacted with an acyl halide or a corresponding anhydride to obtain oxime ester carbazole derivative compounds represented by Chemical Formulas 1-1 to 1-30.

[반응식 2][Scheme 2]

Figure pat00018
Figure pat00018

상기 반응식 2에 따라, 화학식 2-1 내지 2-24의 화합물을 합성하였다. According to Scheme 2, compounds of Formulas 2-1 to 2-24 were synthesized.

우선 상기 반응식 1에 따라 준비된 2-할로 에틸에테르 카르바졸을 상기 반응식 2에 따라 아실 클로라이드를 루이스 산(Lewis acid) 존재 하에 Fridel-Craft 반응을 거쳐 상응하는 케톤 화합물을 얻었다. First, 2-halo ethyl ether carbazole prepared according to Scheme 1 was subjected to Fridel-Craft reaction with acyl chloride according to Scheme 2 in the presence of Lewis acid to obtain a corresponding ketone compound.

상기 케톤 화합물을 질산과 반응시켜 카르바졸 고리에 니트로기를 도입하고 강염기 존재 하에서 아질산 알킬과 반응시켜 상응하는 α-케토 옥심 화합물을 얻었다. The ketone compound was reacted with nitric acid to introduce a nitro group into the carbazole ring and reacted with alkyl nitrite in the presence of a strong base to obtain the corresponding α-keto oxime compound.

상기 α-케토 옥심 화합물을 아실 할라이드 또는 상응하는 언하이드라이드와 반응시켜 상기 화학식 2-1 내지 2-24로 표현되는 α-케토옥심에스테르 카르바졸 화합물의 유도체를 수득하였다.The α-keto oxime compound was reacted with an acyl halide or a corresponding anhydride to obtain a derivative of the α-ketooxime ester carbazole compound represented by Chemical Formulas 2-1 to 2-24.

이하에서 더욱 구체적인 실시예를 설명한다. A more specific example will be described below.

<실시예 1> 화학식 1-17 화합물의 합성<Example 1> Synthesis of compounds of Formula 1-17

[화학식 1-17][Formula 1-17]

Figure pat00019
Figure pat00019

1 단계: 9-(2-(2-(2-chloroethoxy)ethoxy)ethyl)-9H-carbazole 의 합성Step 1: Synthesis of 9-(2-(2-(2-chloroethoxy)ethoxy)ethyl)-9H-carbazole

질소 분위기 하에서 카르바졸 (16.7 g, 0.1 mol)을 DMF (160 mL)이 들어있는 반응기에 투입 후 교반하였다. 카르바졸이 용해된 것을 확인 후 NaOH (8.0 g, 0.2 mol)을 투입하고 실온에서 교반하면서 1,2-bis(2-chloroethoxy)ethane (37.2 g, 0.2 mol)을 10 분에 걸쳐 적하한다. 카르바졸이 소진된 것을 TLC로 확인한 후, 증류수 (200 mL)에 대해 반응액을 적가하고 DCM (200 mL)을 추가로 투입하였다. 추출된 유기층에 대해서 3 회에 걸쳐 증류수 (200 mL X 3 회)를 투입하여 세척하였다. 유기층을 감압농축한 후 농축액은 실리카젤 컬럼 크로마토그래피 (n-Hex./E.A. = 3/1)을 이용한 정제 과정을 거쳐 미백색 고체 27.6 g을 87 % 수율로 획득하였다. Carbazole (16.7 g, 0.1 mol) was added to a reactor containing DMF (160 mL) under a nitrogen atmosphere and stirred. After confirming that the carbazole is dissolved, NaOH (8.0 g, 0.2 mol) is added, and 1,2-bis(2-chloroethoxy)ethane (37.2 g, 0.2 mol) is added dropwise over 10 minutes while stirring at room temperature. After confirming that carbazole was consumed by TLC, the reaction solution was added dropwise to distilled water (200 mL), and DCM (200 mL) was further added. The extracted organic layer was washed by adding distilled water (200 mL X 3 times) three times. After the organic layer was concentrated under reduced pressure, the concentrate was purified by silica gel column chromatography (n-Hex./E.A. = 3/1) to obtain 27.6 g of an off-white solid in 87% yield.

1H-NMR로 생성물을 확인하였다. 1 H-NMR confirmed the product.

1H-NMR (δ, ppm), CDCl3: 8.07 (d/d, 2H), 7.44 (m, 4H), 7.22 (m, 2H), 4.48 (t, 2H), 3.85 (t, 2H), 3.75-3.60 (m, 8H). 1 H-NMR (δ, ppm), CDCl 3 : 8.07 (d/d, 2H), 7.44 (m, 4H), 7.22 (m, 2H), 4.48 (t, 2H), 3.85 (t, 2H), 3.75-3.60 (m, 8H).

2 단계: 1-(9-(2-(2-(2-chloroethoxy)ethoxy)ethyl)-9H-carbazolStep 2: 1-(9-(2-(2-(2-chloroethoxy)ethoxy)ethyl)-9H-carbazol

-3-yl)octan-1-one 의 합성Synthesis of -3-yl)octan-1-one

질소 분위기 하에서 DCM (80 mL)에 침전되어 있는 AlCl3 (9.2 g, 69 mmol)에 대해서 상기 1 단계 화합물 (20.0 g, 63 mmol)을 넣은 후, ice-bath를 이용하여 반응 용액을 냉각시켰다. 옥타노일 클로라이드 (11.2 g, 69 mmol)을 DCM (20 mL)에 녹인 후 반응액에 대해 30 분간에 걸쳐 천천히 적하한다. 적하 완료 후 ice-bath를 제거하고 실온에서 2 시간 동안 교반하였다. The compound from Step 1 (20.0 g, 63 mmol) was added to AlCl3 (9.2 g, 69 mmol) precipitated in DCM (80 mL) under a nitrogen atmosphere, and then the reaction solution was cooled using an ice-bath. After dissolving octanoyl chloride (11.2 g, 69 mmol) in DCM (20 mL), it is slowly added dropwise to the reaction solution over 30 minutes. After completion of the dropping, the ice-bath was removed and the mixture was stirred at room temperature for 2 hours.

반응 종결을 TLC로 확인한 후, 충분히 냉각시킨 10 % HCl (200 mL) 수용액에 대해서 반응 용액을 천천히 적하한다. 반응 용액 중 유기층은 DCM (100 mL)을 이용하여 추출하고 5 % NaOH (200 mL)와 증류수 (200 mL)로 수세한 후, 감압 조건에서 농축하였다. After confirming the completion of the reaction by TLC, the reaction solution is slowly added dropwise to a sufficiently cooled 10% HCl (200 mL) aqueous solution. The organic layer in the reaction solution was extracted using DCM (100 mL), washed with 5% NaOH (200 mL) and distilled water (200 mL), and then concentrated under reduced pressure.

농축액은 실리카젤 컬럼 크로마토그래피 (n-Hex./E.A. = 2/1)을 이용한 정제 과정을 거쳐 엷은 노란색 고체 25.4 g을 91 % 수율로 획득하였다.The concentrate was purified by silica gel column chromatography (n-Hex./E.A. = 2/1) to obtain 25.4 g of a pale yellow solid in 91% yield.

1H-NMR로 생성물을 확인하였다. 1 H-NMR confirmed the product.

1H-NMR (δ, ppm), CDCl3: 8.57 (s, 1H), 8.22 (d, 1H), 8.19 (d, 1H), 7.67-7.32 (m, 4H), 4.49 (t, 2H), 3.89 (t, 2H), 3.54-3.42 (m, 8H), 2.97 (t, 2H), 1.57 (m, 2H), 1.43-1.24 (m, 8H), 0.89 (t, 3H). 1 H-NMR (δ, ppm), CDCl 3 : 8.57 (s, 1H), 8.22 (d, 1H), 8.19 (d, 1H), 7.67-7.32 (m, 4H), 4.49 (t, 2H), 3.89 (t, 2H), 3.54-3.42 (m, 8H), 2.97 (t, 2H), 1.57 (m, 2H), 1.43-1.24 (m, 8H), 0.89 (t, 3H).

3 단계: 1-(9-(2-(2-(2-chloroethoxy)ethoxy)ethyl)-6-nitro-9H-Step 3: 1-(9-(2-(2-(2-chloroethoxy)ethoxy)ethyl)-6-nitro-9H-

carbazol-3-yl)octan-1-one 의 합성Synthesis of carbazol-3-yl)octan-1-one

질소 분위기 하에서 아세트산 용액 (150 mL)에 대해 상기 2 단계 화합물 (22 g, 50 mmol)을 넣은 후 교반하였다. 교반 중인 반응액에 대해 질산 (9.4 g, 100 mmol)을 30 °C 이하로 온도를 유지하면서 30 분간에 걸쳐 서서히 적하하고 2 시간 동안 교반하였다. The compound from Step 2 (22 g, 50 mmol) was added to an acetic acid solution (150 mL) under a nitrogen atmosphere, followed by stirring. Nitric acid (9.4 g, 100 mmol) was slowly added dropwise to the stirred reaction solution over 30 minutes while maintaining the temperature at 30 °C or less, followed by stirring for 2 hours.

반응 종결을 TLC 로 확인한 후, 증류수 (200 mL)에 반응액을 적가하고 추가적으로 30 분 교반하였다. DCM (200 mL)을 투입하여 유기층을 분리한 후, 증류수 (200 mL X 3 회)을 투입하여 유기층을 세척하고 감압 농축하였다. 농축액은 극성 및 비극성 용매를 이용한 재결정 과정을 거쳐 노란색 고체 20.5 g을 84 % 수율로 획득하였다. After confirming the completion of the reaction by TLC, the reaction solution was added dropwise to distilled water (200 mL) and stirred for additional 30 minutes. After DCM (200 mL) was added to separate the organic layer, distilled water (200 mL X 3 times) was added to wash the organic layer, and the mixture was concentrated under reduced pressure. The concentrate was recrystallized using polar and non-polar solvents to obtain 20.5 g of a yellow solid in 84% yield.

1H-NMR로 생성물을 확인하였다. 1 H-NMR confirmed the product.

1H-NMR (δ, ppm), CDCl3: 9.04 (s, 1H), 8.51 (s, 1H), 8.37 (d/d, 1H), 7.97 (d/d, 1H), 7.54 (m, 2H), 4.55 (t, 2H), 3.93 (t, 2H), 3.57-3.47 (m, 8H), 2.98 (t, 2H), 1.59 (m, 2H), 1.43-1.26 (m, 8H), 0.88 (t, 3H). 1H-NMR (δ, ppm), CDCl 3 : 9.04 (s, 1H), 8.51 (s, 1H), 8.37 (d/d, 1H), 7.97 (d/d, 1H), 7.54 (m, 2H) , 4.55 (t, 2H), 3.93 (t, 2H), 3.57-3.47 (m, 8H), 2.98 (t, 2H), 1.59 (m, 2H), 1.43-1.26 (m, 8H), 0.88 (t) , 3H).

4단계: 1-(9-(2-(2-(2-chloroethoxy)ethoxy)ethyl)-6-nitro-9H-Step 4: 1-(9-(2-(2-(2-chloroethoxy)ethoxy)ethyl)-6-nitro-9H-

carbazol-3-yl)octan-1-one oxime 의 합성Synthesis of carbazol-3-yl)octan-1-one oxime

질소 분위기 하에서 상기 3 단계 화합물 (18.0 g, 37 mmol)을 에탄올 (120 mL)에 넣는다. 반응 용액에 대해 염산 하이드록실아민 (2.8 g, 41 mmol)과 초산나트륨 3수화물 (5.6 g, 41 mmol)을 투입하고 승온하여 환류시키면서 4 시간 동안 교반하였다.The compound from Step 3 (18.0 g, 37 mmol) was placed in ethanol (120 mL) under a nitrogen atmosphere. Hydroxylamine hydrochloride (2.8 g, 41 mmol) and sodium acetate trihydrate (5.6 g, 41 mmol) were added to the reaction solution, and the temperature was raised to reflux, followed by stirring for 4 hours.

반응 종결을 TLC 로 확인한 후, 반응액을 실온으로 냉각하고 증류수 (200 mL)를 투입하여 quenching 한다. DCM (200 mL)을 투입하여 추출한 유기층을 증류수 (200 mL)로 3 회 수세한 후, 감압 조건에서 농축한다. 농축 후 수득된 노란색 고체 17.9 g은 추가적인 정제 과정 없이 다음 반응에 사용한다.After confirming the completion of the reaction by TLC, the reaction solution is cooled to room temperature, and distilled water (200 mL) is added to perform quenching. The organic layer extracted by adding DCM (200 mL) was washed with distilled water (200 mL) three times, and then concentrated under reduced pressure. 17.9 g of the yellow solid obtained after concentration was used for the next reaction without further purification.

1H-NMR로 생성물을 확인하였다. 1 H-NMR confirmed the product.

1H-NMR (δ, ppm), CDCl3: 9.02 (s, 1H), 8.45 (s, 1H), 8.38 (d/d, 1H), 7.99 (d/d, 1H), 7.53 (m, 2H), 4.56 (t, 2H), 3.92 (t, 2H), 3.57-3.47 (m, 8H), 2.92 (t, 2H), 1.60 (m, 2H), 1.43-1.26 (m, 8H), 0.88 (t, 3H). 1 H-NMR (δ, ppm), CDCl 3 : 9.02 (s, 1H), 8.45 (s, 1H), 8.38 (d/d, 1H), 7.99 (d/d, 1H), 7.53 (m, 2H) ), 4.56 (t, 2H), 3.92 (t, 2H), 3.57-3.47 (m, 8H), 2.92 (t, 2H), 1.60 (m, 2H), 1.43-1.26 (m, 8H), 0.88 ( t, 3H).

5단계: 1-(9-(2-(2-(2-chloroethoxy)ethoxy)ethyl)-6-nitro-9H-Step 5: 1-(9-(2-(2-(2-chloroethoxy)ethoxy)ethyl)-6-nitro-9H-

carbazol-3-yl)octan-1-one O-acetyl oxime 의 합성 Synthesis of carbazol-3-yl)octan-1-one O-acetyl oxime

질소 분위기 하에서 상기 4 단계 화합물 (15.0 g, 30 mmol)을 DCM (80 mL)에 녹인 후, 아세트산무수물 (3.4 g, 33 mmol)을 서서히 적하하였다. 적하 완료 후 반응 용기를 알루미늄 호일을 이용하여 빛을 차단하고 4 시간 동안 실온에서 교반하였다.The compound from Step 4 (15.0 g, 30 mmol) was dissolved in DCM (80 mL) under a nitrogen atmosphere, and then acetic anhydride (3.4 g, 33 mmol) was slowly added dropwise. After completion of the dropping, the reaction vessel was blocked from light using aluminum foil and stirred at room temperature for 4 hours.

반응 종결을 TLC 로 확인한 후, 반응액에 증류수 (200 mL)와 DCM (120 mL)을 투입한다. 수득된 유기층을 증류수 (200 mL)로 3 회 수세한 후, 감압 조건에서 농축한다. 농축액은 극성 및 비극성 용매를 이용한 재결정 과정을 거쳐 노란색 고체 13.4 g을 82 % 수율로 최종 생성물을 획득하였다.After confirming the completion of the reaction by TLC, distilled water (200 mL) and DCM (120 mL) are added to the reaction solution. The obtained organic layer was washed 3 times with distilled water (200 mL), and then concentrated under reduced pressure. The concentrate was subjected to recrystallization using polar and non-polar solvents to obtain a final product in 82% yield of 13.4 g of a yellow solid.

1H-NMR로 카르바졸 유도체 합성을 확인하였다. 1 H-NMR confirmed the synthesis of the carbazole derivative.

1H-NMR (δ, ppm), CDCl3: 9.03 (s, 1H), 8.45 (s, 1H), 8.38 (d/d, 1H), 7.99 (d/d, 1H), 7.53 (m, 2H), 4.56 (t, 2H), 3.92 (t, 2H), 3.57-3.47 (m, 8H), 2.98 (t, 2H), 2.29 (s, 3H), 1.63 (m, 2H), 1.44-1.26 (m, 8H), 0.87 (t, 3H). 1 H-NMR (δ, ppm), CDCl 3 : 9.03 (s, 1H), 8.45 (s, 1H), 8.38 (d/d, 1H), 7.99 (d/d, 1H), 7.53 (m, 2H) ), 4.56 (t, 2H), 3.92 (t, 2H), 3.57-3.47 (m, 8H), 2.98 (t, 2H), 2.29 (s, 3H), 1.63 (m, 2H), 1.44-1.26 ( m, 8H), 0.87 (t, 3H).

화학식 1-1 내지 1-10으로 표현되는 옥심에스테르 카르바졸 유도체 화합물들은 염기 존재 하에서 카르바졸 고리 내 질소 원자와 1-chloro-2-(2-chloroethoxy)ethane과의 SN2 반응으로부터 준비된 9-(2-(2-chloroethoxy) ethyl)-9H-carbazole을 출발물질로 하여 실시예 1의 제조방법에 따라 표 1과 같이 합성하였다. The oxime ester carbazole derivative compounds represented by Formulas 1-1 to 1-10 are 9- prepared from the S N 2 reaction of 1-chloro-2-(2-chloroethoxy)ethane with a nitrogen atom in the carbazole ring in the presence of a base. (2-(2-chloroethoxy)ethyl)-9H-carbazole was synthesized as shown in Table 1 according to the preparation method of Example 1 as a starting material.

화학식 No.Formula No. R1 R 1 R2 R 2 1H-NMR (δ, ppm) 1 H-NMR (δ, ppm) 1-11-1 CH3 CH 3 CH3 CH 3 9.04 (s, 1H), 8.43 (s, 1H), 8.37 (d/d, 1H), 8.01 (d/d, 1H), 7.52 (m, 2H), 4.54 (t, 2H), 3.96 (t, 2H), 3.59 (t, 2H), 3.46 (t, 2H), 2.92 (s, 3H), 2.32 (s, 3H).9.04 (s, 1H), 8.43 (s, 1H), 8.37 (d/d, 1H), 8.01 (d/d, 1H), 7.52 (m, 2H), 4.54 (t, 2H), 3.96 (t, 2H), 3.59 (t, 2H), 3.46 (t, 2H), 2.92 (s, 3H), 2.32 (s, 3H). 1-21-2 C2H5 C 2 H 5 CH3 CH 3 9.04 (s, 1H), 8.42 (s, 1H), 8.36 (d/d, 1H), 7.99 (d/d, 1H), 7.53 (m, 2H), 4.54 (t, 2H), 3.95 (t, 2H), 3.58 (t, 2H), 3.47 (t, 2H), 2.90 (q, 2H), 2.32 (s, 3H), 1.12 (t, 3H).9.04 (s, 1H), 8.42 (s, 1H), 8.36 (d/d, 1H), 7.99 (d/d, 1H), 7.53 (m, 2H), 4.54 (t, 2H), 3.95 (t, 2H), 3.58 (t, 2H), 3.47 (t, 2H), 2.90 (q, 2H), 2.32 (s, 3H), 1.12 (t, 3H). 1-31-3 C3H7 C 3 H 7 CH3 CH 3 9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.52 (m, 2H), 4.54 (t, 2H), 3.96 (t, 2H), 3.59 (t, 2H), 3.45 (t, 2H), 2.87 (t, 2H), 2.31 (s, 3H), 1.69 (m, 2H), 1.02 (t, 3H).9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.52 (m, 2H), 4.54 (t, 2H), 3.96 (t, 2H), 3.59 (t, 2H), 3.45 (t, 2H), 2.87 (t, 2H), 2.31 (s, 3H), 1.69 (m, 2H), 1.02 (t, 3H). 1-41-4 C4H9 C 4 H 9 CH3 CH 3 9.03 (s, 1H), 8.43 (s, 1H), 8.36 (d/d, 1H), 7.99 (d/d, 1H), 7.52 (m, 2H), 4.53 (t, 2H), 3.95 (t, 2H), 3.60 (t, 2H), 3.45 (t, 2H), 2.86 (t, 2H), 2.31 (s, 3H), 1.62-1.43 (m, 4H), 0.96 (t, 3H).9.03 (s, 1H), 8.43 (s, 1H), 8.36 (d/d, 1H), 7.99 (d/d, 1H), 7.52 (m, 2H), 4.53 (t, 2H), 3.95 (t, 2H), 3.60 (t, 2H), 3.45 (t, 2H), 2.86 (t, 2H), 2.31 (s, 3H), 1.62-1.43 (m, 4H), 0.96 (t, 3H). 1-51-5 C5H11 C 5 H 11 CH3 CH 3 9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.97 (d/d, 1H), 7.53 (m, 2H), 4.53 (t, 2H), 3.95 (t, 2H), 3.60 (t, 2H), 3.44 (t, 2H), 2.84 (t, 2H), 2.30 (s, 3H), 1.59-1.37 (m, 6H), 0.93 (t, 3H).9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.97 (d/d, 1H), 7.53 (m, 2H), 4.53 (t, 2H), 3.95 (t, 2H), 3.60 (t, 2H), 3.44 (t, 2H), 2.84 (t, 2H), 2.30 (s, 3H), 1.59-1.37 (m, 6H), 0.93 (t, 3H). 1-61-6 C6H13 C 6 H 13 CH3 CH 3 9.03 (s, 1H), 8.43 (s, 1H), 8.36 (d/d, 1H), 7.98 (d/d, 1H), 7.52 (m, 2H), 4.52 (t, 2H), 3.93 (t, 2H), 3.59 (t, 2H), 3.45 (t, 2H), 2.82 (t, 2H), 2.30 (s, 3H), 1.55-1.33 (m, 8H), 0.89 (t, 3H).9.03 (s, 1H), 8.43 (s, 1H), 8.36 (d/d, 1H), 7.98 (d/d, 1H), 7.52 (m, 2H), 4.52 (t, 2H), 3.93 (t, 2H), 3.59 (t, 2H), 3.45 (t, 2H), 2.82 (t, 2H), 2.30 (s, 3H), 1.55-1.33 (m, 8H), 0.89 (t, 3H). 1-71-7 C7H15 C 7 H 15 CH3 CH 3 9.03 (s, 1H), 8.44 (s, 1H), 8.37 (d/d, 1H), 7.97 (d/d, 1H), 7.51 (m, 2H), 4.51 (t, 2H), 3.93 (t, 2H), 3.58 (t, 2H), 3.45 (t, 2H), 2.80 (t, 2H), 2.29 (s, 3H), 1.48-1.30 (m, 10H), 0.87 (t, 3H).9.03 (s, 1H), 8.44 (s, 1H), 8.37 (d/d, 1H), 7.97 (d/d, 1H), 7.51 (m, 2H), 4.51 (t, 2H), 3.93 (t, 2H), 3.58 (t, 2H), 3.45 (t, 2H), 2.80 (t, 2H), 2.29 (s, 3H), 1.48-1.30 (m, 10H), 0.87 (t, 3H). 1-81-8 C6H11 C 6 H 11 CH3 CH 3 9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.53 (m, 2H), 4.54 (t, 2H), 3.96 (t, 2H), 3.60 (t, 2H), 3.45 (t, 2H), 2.71 (m, 1H), 2.27 (s, 3H), 1.80-1.29 (m, 10H). 9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.53 (m, 2H), 4.54 (t, 2H), 3.96 (t, 2H), 3.60 (t, 2H), 3.45 (t, 2H), 2.71 (m, 1H), 2.27 (s, 3H), 1.80-1.29 (m, 10H). 1-91-9 C7H7 C 7 H 7 CH3 CH 3 9.03 (s, 1H), 8.45 (s, 1H), 8.38 (d/d, 1H), 7.99 (d/d, 1H), 7.63 (d, 1H), 7.53 (m, 2H), 7.48-7.12 (m, 3H), 4.54 (t, 2H), 3.96 (t, 2H), 3.61 (t, 2H), 3.46 (t, 2H), 2.43 (s, 3H), 2.29 (s, 3H). 9.03 (s, 1H), 8.45 (s, 1H), 8.38 (d/d, 1H), 7.99 (d/d, 1H), 7.63 (d, 1H), 7.53 (m, 2H), 7.48-7.12 ( m, 3H), 4.54 (t, 2H), 3.96 (t, 2H), 3.61 (t, 2H), 3.46 (t, 2H), 2.43 (s, 3H), 2.29 (s, 3H). 1-101-10 C7H15 C 7 H 15 C6H5 C 6 H 5 9.02 (s, 1H), 8.42 (s, 1H), 8.39 (d/d, 1H), 8.19 (d/d, 1H), 8.01 (d/d, 1H), 7.98 (d/d, 1H), 7.72-7.59 (m, 3H), 7.54 (m, 2H), 4.54 (t, 2H), 3.96 (t, 2H), 3.61 (t, 2H), 3.46 (t, 2H), 2.82 (t, 2H), 1.48-1.30 (m, 10H), 0.87 (t, 3H).9.02 (s, 1H), 8.42 (s, 1H), 8.39 (d/d, 1H), 8.19 (d/d, 1H), 8.01 (d/d, 1H), 7.98 (d/d, 1H), 7.72-7.59 (m, 3H), 7.54 (m, 2H), 4.54 (t, 2H), 3.96 (t, 2H), 3.61 (t, 2H), 3.46 (t, 2H), 2.82 (t, 2H) , 1.48-1.30 (m, 10H), 0.87 (t, 3H).

화학식 1-11 내지 1-16 그리고 1-18 내지 1-20으로 표현되는 옥심에스테르 카르바졸 유도체 화합물들은 실시예 1의 제조방법에 따라 표 2와 같이 합성하였다. Oxime ester carbazole derivative compounds represented by Chemical Formulas 1-11 to 1-16 and 1-18 to 1-20 were synthesized as shown in Table 2 according to the preparation method of Example 1.

화학식 No.Formula No. R1 R 1 R2 R 2 1H-NMR (δ, ppm) 1 H-NMR (δ, ppm) 1-111-11 CH3 CH 3 CH3 CH 3 9.04 (s, 1H), 8.43 (s, 1H), 8.37 (d/d, 1H), 8.01 (d/d, 1H), 7.52 (m, 2H), 4.57 (t, 2H), 3.91 (t, 2H), 3.58-3.45 (m, 8H), 2.92 (s, 3H), 2.32 (s, 3H).9.04 (s, 1H), 8.43 (s, 1H), 8.37 (d/d, 1H), 8.01 (d/d, 1H), 7.52 (m, 2H), 4.57 (t, 2H), 3.91 (t, 2H), 3.58-3.45 (m, 8H), 2.92 (s, 3H), 2.32 (s, 3H). 1-121-12 C2H5 C 2 H 5 CH3 CH 3 9.04 (s, 1H), 8.43 (s, 1H), 8.37 (d/d, 1H), 7.99 (d/d, 1H), 7.53 (m, 2H), 4.56 (t, 2H), 3.92 (t, 2H), 3.57-3.45 (m, 8H), 2.90 (q, 2H), 2.32 (s, 3H), 1.09 (t, 3H).9.04 (s, 1H), 8.43 (s, 1H), 8.37 (d/d, 1H), 7.99 (d/d, 1H), 7.53 (m, 2H), 4.56 (t, 2H), 3.92 (t, 2H), 3.57-3.45 (m, 8H), 2.90 (q, 2H), 2.32 (s, 3H), 1.09 (t, 3H). 1-131-13 C3H7 C 3 H 7 CH3 CH 3 9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.52 (m, 2H), 4.56 (t, 2H), 3.91 (t, 2H), 3.56-3.43 (m, 8H), 2.87 (t, 2H), 2.31 (s, 3H), 1.68 (m, 2H), 1.03 (t, 3H).9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.52 (m, 2H), 4.56 (t, 2H), 3.91 (t, 2H), 3.56-3.43 (m, 8H), 2.87 (t, 2H), 2.31 (s, 3H), 1.68 (m, 2H), 1.03 (t, 3H). 1-141-14 C4H9 C 4 H 9 CH3 CH 3 9.03 (s, 1H), 8.43 (s, 1H), 8.37 (d/d, 1H), 7.99 (d/d, 1H), 7.52 (m, 2H), 4.55 (t, 2H), 3.92 (t, 2H), 3.56-3.42 (m, 8H), 2.86 (t, 2H), 2.31 (s, 3H), 1.62-1.43 (m, 4H), 0.96 (t, 3H).9.03 (s, 1H), 8.43 (s, 1H), 8.37 (d/d, 1H), 7.99 (d/d, 1H), 7.52 (m, 2H), 4.55 (t, 2H), 3.92 (t, 2H), 3.56-3.42 (m, 8H), 2.86 (t, 2H), 2.31 (s, 3H), 1.62-1.43 (m, 4H), 0.96 (t, 3H). 1-151-15 C5H11 C 5 H 11 CH3 CH 3 9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.51 (m, 2H), 4.54 (t, 2H), 3.93 (t, 2H), 3.56-3.43 (m, 8H), 2.83 (t, 2H), 2.29 (s, 3H), 1.58-1.37 (m, 6H), 0.93 (t, 3H).9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.51 (m, 2H), 4.54 (t, 2H), 3.93 (t, 2H), 3.56-3.43 (m, 8H), 2.83 (t, 2H), 2.29 (s, 3H), 1.58-1.37 (m, 6H), 0.93 (t, 3H). 1-161-16 C6H13 C 6 H 13 CH3 CH 3 9.03 (s, 1H), 8.43 (s, 1H), 8.36 (d/d, 1H), 7.96 (d/d, 1H), 7.50 (m, 2H), 4.55 (t, 2H), 3.92 (t, 2H), 3.56-3.42 (m, 8H), 2.83 (t, 2H), 2.28 (s, 3H), 1.56-1.33 (m, 8H), 0.89 (t, 3H).9.03 (s, 1H), 8.43 (s, 1H), 8.36 (d/d, 1H), 7.96 (d/d, 1H), 7.50 (m, 2H), 4.55 (t, 2H), 3.92 (t, 2H), 3.56-3.42 (m, 8H), 2.83 (t, 2H), 2.28 (s, 3H), 1.56-1.33 (m, 8H), 0.89 (t, 3H). 1-181-18 C6H11 C 6 H 11 CH3 CH 3 9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.52 (m, 2H), 4.56 (t, 2H), 3.92 (t, 2H), 3.55-3.42 (m, 8H), 2.69 (m, 1H), 2.25 (s, 3H), 1.88-1.25 (m, 10H). 9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.52 (m, 2H), 4.56 (t, 2H), 3.92 (t, 2H), 3.55-3.42 (m, 8H), 2.69 (m, 1H), 2.25 (s, 3H), 1.88-1.25 (m, 10H). 1-191-19 C7H7 C 7 H 7 CH3 CH 3 9.03 (s, 1H), 8.45 (s, 1H), 8.38 (d/d, 1H), 7.99 (d/d, 1H), 7.63 (d, 1H), 7.53 (m, 2H), 7.48-7.12 (m, 3H), 4.55 (t, 2H), 3.91 (t, 2H), 3.58-3.45 (m, 8H), 2.35 (s, 3H), 2.29 (s, 3H).9.03 (s, 1H), 8.45 (s, 1H), 8.38 (d/d, 1H), 7.99 (d/d, 1H), 7.63 (d, 1H), 7.53 (m, 2H), 7.48-7.12 ( m, 3H), 4.55 (t, 2H), 3.91 (t, 2H), 3.58-3.45 (m, 8H), 2.35 (s, 3H), 2.29 (s, 3H). 1-201-20 C7H15 C 7 H 15 C6H5 C 6 H 5 9.02 (s, 1H), 8.42 (s, 1H), 8.39 (d/d, 1H), 8.19 (d/d, 1H), 8.01 (d/d, 1H), 7.98 (d/d, 1H), 7.72-7.58 (m, 3H), 7.55 (m, 2H), 4.54 (t, 2H), 3.94 (t, 2H), 3.59-3.46 (m, 8H), 3.01 (t, 2H), 2.26 (s, 3H), 1.63 (m, 2H), 1.46-1.23 (m, 8H), 0.88 (t, 3H).9.02 (s, 1H), 8.42 (s, 1H), 8.39 (d/d, 1H), 8.19 (d/d, 1H), 8.01 (d/d, 1H), 7.98 (d/d, 1H), 7.72-7.58 (m, 3H), 7.55 (m, 2H), 4.54 (t, 2H), 3.94 (t, 2H), 3.59-3.46 (m, 8H), 3.01 (t, 2H), 2.26 (s, 3H), 1.63 (m, 2H), 1.46-1.23 (m, 8H), 0.88 (t, 3H).

화학식 1-21 내지 1-30으로 표현되는 옥심에스테르 카르바졸 유도체 화합물들은 염기 존재 하에서 카르바졸 고리 내 질소 원자와 1-chloro-2-(2- (2-(2-chloroethoxy)ethoxy)ethoxy)ethane의 SN2 반응으로부터 준비된 9-(2-(2-(3-(2-chloroethoxy)propoxy)ethoxy)ethyl)-9H-carbazole을 출발물질로 하여 실시예 1의 제조방법에 준하여 표 3과 같이 합성하였다. The oxime ester carbazole derivative compounds represented by Formulas 1-21 to 1-30 have a nitrogen atom in the carbazole ring and 1-chloro-2-(2-(2-(2-chloroethoxy)ethoxy)ethoxy)ethane in the presence of a base. 9-(2-(2-(3-(2-chloroethoxy)propoxy)ethoxy)ethyl)-9H-carbazole prepared from the S N 2 reaction of synthesized.

화학식 No.Formula No. R1 R 1 R2 R 2 1H-NMR (δ, ppm) 1 H-NMR (δ, ppm) 1-211-21 CH3 CH 3 CH3 CH 3 9.05 (s, 1H), 8.44 (s, 1H), 8.36 (d/d, 1H), 8.01 (d/d, 1H), 7.52 (m, 2H), 4.57 (t, 2H), 3.93 (t, 2H), 3.61-3.49 (m, 12H), 2.92 (s, 3H), 2.32 (s, 3H).9.05 (s, 1H), 8.44 (s, 1H), 8.36 (d/d, 1H), 8.01 (d/d, 1H), 7.52 (m, 2H), 4.57 (t, 2H), 3.93 (t, 2H), 3.61-3.49 (m, 12H), 2.92 (s, 3H), 2.32 (s, 3H). 1-221-22 C2H5 C 2 H 5 CH3 CH 3 9.04 (s, 1H), 8.43 (s, 1H), 8.36 (d/d, 1H), 8.01 (d/d, 1H), 7.53 (m, 2H), 4.57 (t, 2H), 3.93 (t, 2H), 3.61-3.50 (m, 12H), 2.90 (q, 2H), 2.32 (s, 3H), 1.12 (t, 3H).9.04 (s, 1H), 8.43 (s, 1H), 8.36 (d/d, 1H), 8.01 (d/d, 1H), 7.53 (m, 2H), 4.57 (t, 2H), 3.93 (t, 2H), 3.61-3.50 (m, 12H), 2.90 (q, 2H), 2.32 (s, 3H), 1.12 (t, 3H). 1-231-23 C3H7 C 3 H 7 CH3 CH 3 9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.52 (m, 2H), 4.57 (t, 2H), 3.93 (t, 2H), 3.60-3.48 (m, 12H), 2.87 (t, 2H), 2.31 (s, 3H), 1.68 (m, 2H), 1.02 (t, 3H).9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.52 (m, 2H), 4.57 (t, 2H), 3.93 (t, 2H), 3.60-3.48 (m, 12H), 2.87 (t, 2H), 2.31 (s, 3H), 1.68 (m, 2H), 1.02 (t, 3H). 1-241-24 C4H9 C 4 H 9 CH3 CH 3 9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.99 (d/d, 1H), 7.51 (m, 2H), 4.56 (t, 2H), 3.94 (t, 2H), 3.59-3.45 (m, 12H), 2.85 (t, 2H), 2.29 (s, 3H), 1.60-1.40 (m, 4H), 0.96 (t, 3H).9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.99 (d/d, 1H), 7.51 (m, 2H), 4.56 (t, 2H), 3.94 (t, 2H), 3.59-3.45 (m, 12H), 2.85 (t, 2H), 2.29 (s, 3H), 1.60-1.40 (m, 4H), 0.96 (t, 3H). 1-251-25 C5H11 C 5 H 11 CH3 CH 3 9.03 (s, 1H), 8.43 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.53 (m, 2H), 4.56 (t, 2H), 3.93 (t, 2H), 3.60-3.45 (m, 12H), 2.82 (t, 2H), 2.30 (s, 3H), 1.60-1.37 (m, 6H), 0.93 (t, 3H).9.03 (s, 1H), 8.43 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.53 (m, 2H), 4.56 (t, 2H), 3.93 (t, 2H), 3.60-3.45 (m, 12H), 2.82 (t, 2H), 2.30 (s, 3H), 1.60-1.37 (m, 6H), 0.93 (t, 3H). 1-261-26 C6H13 C 6 H 13 CH3 CH 3 9.03 (s, 1H), 8.43 (s, 1H), 8.38 (d/d, 1H), 7.99 (d/d, 1H), 7.52 (m, 2H), 4.56 (t, 2H), 3.92 (t, 2H), 3.61-3.42 (m, 12H), 2.85 (t, 2H), 2.29 (s, 3H), 1.55-1.33 (m, 8H), 0.89 (t, 3H).9.03 (s, 1H), 8.43 (s, 1H), 8.38 (d/d, 1H), 7.99 (d/d, 1H), 7.52 (m, 2H), 4.56 (t, 2H), 3.92 (t, 2H), 3.61-3.42 (m, 12H), 2.85 (t, 2H), 2.29 (s, 3H), 1.55-1.33 (m, 8H), 0.89 (t, 3H). 1-271-27 C7H15 C 7 H 15 CH3 CH 3 9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.52 (m, 2H), 4.55 (t, 2H), 3.92 (t, 2H), 3.60-3.42 (m, 12H), 2.84 (t, 2H), 2.28 (s, 3H), 1.48-1.30 (m, 10H), 0.87 (t, 3H).9.03 (s, 1H), 8.44 (s, 1H), 8.38 (d/d, 1H), 7.98 (d/d, 1H), 7.52 (m, 2H), 4.55 (t, 2H), 3.92 (t, 2H), 3.60-3.42 (m, 12H), 2.84 (t, 2H), 2.28 (s, 3H), 1.48-1.30 (m, 10H), 0.87 (t, 3H). 1-281-28 C6H11 C 6 H 11 CH3 CH 3 9.03 (s, 1H), 8.44 (s, 1H), 8.36 (d/d, 1H), 7.97 (d/d, 1H), 7.53 (m, 2H), 4.54 (t, 2H), 3.96 (t, 2H), 3.60 (t, 2H), 3.45 (t, 2H), 2.65 (m, 1H), 2.27 (s, 3H), 1.80-1.21 (m, 10H). 9.03 (s, 1H), 8.44 (s, 1H), 8.36 (d/d, 1H), 7.97 (d/d, 1H), 7.53 (m, 2H), 4.54 (t, 2H), 3.96 (t, 2H), 3.60 (t, 2H), 3.45 (t, 2H), 2.65 (m, 1H), 2.27 (s, 3H), 1.80-1.21 (m, 10H). 1-291-29 C7H7 C 7 H 7 CH3 CH 3 9.03 (s, 1H), 8.45 (s, 1H), 8.38 (d/d, 1H), 7.99 (d/d, 1H), 7.63 (d, 1H), 7.53 (m, 2H), 7.48-7.12 (m, 3H), 4.57 (t, 2H), 3.94 (t, 2H), 3.59-3.44 (m, 12H), 2.43 (s, 3H), 2.29 (s, 3H). 9.03 (s, 1H), 8.45 (s, 1H), 8.38 (d/d, 1H), 7.99 (d/d, 1H), 7.63 (d, 1H), 7.53 (m, 2H), 7.48-7.12 ( m, 3H), 4.57 (t, 2H), 3.94 (t, 2H), 3.59-3.44 (m, 12H), 2.43 (s, 3H), 2.29 (s, 3H). 1-301-30 C7H15 C 7 H 15 C6H5 C 6 H 5 9.02 (s, 1H), 8.42 (s, 1H), 8.39 (d/d, 1H), 8.19 (d/d, 1H), 8.01 (d/d, 1H), 7.98 (d/d, 1H), 7.72-7.59 (m, 3H), 7.54 (m, 2H), 4.56 (t, 2H), 3.91 (t, 2H), 3.62-3.45 (m, 12H), 2.82 (t, 2H), 1.48-1.30 (m, 10H), 0.87 (t, 3H).9.02 (s, 1H), 8.42 (s, 1H), 8.39 (d/d, 1H), 8.19 (d/d, 1H), 8.01 (d/d, 1H), 7.98 (d/d, 1H), 7.72-7.59 (m, 3H), 7.54 (m, 2H), 4.56 (t, 2H), 3.91 (t, 2H), 3.62-3.45 (m, 12H), 2.82 (t, 2H), 1.48-1.30 ( m, 10H), 0.87 (t, 3H).

실시예 1에 기재된 합성법으로 각 구조에 상응하는 R1, R2 및 n 단위체를 도입하여 화학식 1-1 내지 1-30의 화합물을 제조하였다. Compounds of Formulas 1-1 to 1-30 were prepared by introducing R 1 , R 2 and n units corresponding to each structure by the synthesis method described in Example 1.

<실시예 2> 화학식 2-14 화합물 합성<Example 2> Synthesis of compound of formula 2-14

[화학식 2-14][Formula 2-14]

Figure pat00020
Figure pat00020

1 단계: (1-(9-(2-(2-(2-chloroethoxy)ethoxy)ethyl)-6-nitro-9H- Step 1: (1-(9-(2-(2-(2-chloroethoxy)ethoxy)ethyl)-6-nitro-9H-

carbazol-3-yl)-2-(hydroxyimino)octan-1-one 의 합성Synthesis of carbazol-3-yl)-2-(hydroxyimino)octan-1-one

질소 분위기 하에서 실시예 1의 상기 3 단계 화합물 (15 g, 30 mmol)과 메톡사이드나트륨 (1.7, 32 mmol)을 DCM (50 mL)와 메탄올 (50 mL) 혼합액 (부피비 1:1)에 투입하고 ice-bath를 이용하여 반응 용액을 0 ℃로 냉각시켰다. In a nitrogen atmosphere, the compound of step 3 of Example 1 (15 g, 30 mmol) and sodium methoxide (1.7, 32 mmol) were added to a mixture of DCM (50 mL) and methanol (50 mL) (volume ratio 1:1), and The reaction solution was cooled to 0 °C using an ice-bath.

반응 용액에 대해서 아밀 나이트라이트 (3.7 g, 32 mmol)를 약 30 분간에 걸쳐 서서히 적하하였다. 적하 완료 후 ice-bath를 제거하고 실온에서 2 시간 동안 교반하였다. Amyl nitrite (3.7 g, 32 mmol) was gradually added dropwise to the reaction solution over about 30 minutes. After completion of the dropping, the ice-bath was removed and the mixture was stirred at room temperature for 2 hours.

반응 종결을 TLC로 확인한 후, 10 % HCl (100 mL) 수용액에 대해서 반응 용액을 천천히 적하하여 퀀칭(quenching)하였다. 반응 용액 중 유기층은 DCM (100 mL)을 이용하여 추출하고 수득된 유기층을 증류수 (150 mL)로 3 회 수세한 후, 감압 조건에서 농축하였다. 농축액은 실리카젤 컬럼 크로마토그래피 (n-Hex./E.A. = 2/1)을 이용한 정제 과정을 거쳐 미백색 고체 13.7 g을 88 % 수율로 획득하였다. After confirming the completion of the reaction by TLC, the reaction solution was slowly added dropwise to a 10% HCl (100 mL) aqueous solution to quench (quenching). The organic layer in the reaction solution was extracted using DCM (100 mL), and the obtained organic layer was washed with distilled water (150 mL) three times, and then concentrated under reduced pressure. The concentrate was purified by silica gel column chromatography (n-Hex./E.A. = 2/1) to obtain 13.7 g of an off-white solid in 88% yield.

1H-NMR로 생성물을 확인하였다. 1 H-NMR confirmed the product.

1H-NMR (δ, ppm), CDCl3: 9.00 (s, 1H), 8.63 (s, 1H), 8.31 (d/d, 1H), 8.05 (d/d, 1H), 7.52-7.39 (m, 2H), 4.55 (t, 2H), 3.93 (t, 2H), 3.57-3.47 (m, 8H), 2.64 (t, 2H), 1.52 (m, 2H), 1.39-1.20 (m, 8H), 0.90 (t, 3H). 1 H-NMR (δ, ppm), CDCl 3 : 9.00 (s, 1H), 8.63 (s, 1H), 8.31 (d/d, 1H), 8.05 (d/d, 1H), 7.52-7.39 (m) , 2H), 4.55 (t, 2H), 3.93 (t, 2H), 3.57-3.47 (m, 8H), 2.64 (t, 2H), 1.52 (m, 2H), 1.39-1.20 (m, 8H), 0.90 (t, 3H).

2단계: 2-(acetoxyimino)-1-(9-(2-(2-(2-chloroethoxy)ethoxy) Step 2: 2-(acetoxyimino)-1-(9-(2-(2-(2-chloroethoxy)ethoxy)

ethyl)-6-nitro-9H-carbazol-3-yl)octan-1-one 의 합성Synthesis of ethyl)-6-nitro-9H-carbazol-3-yl)octan-1-one

질소 분위기 하에서 상기 4 단계 화합물 (12.0 g, 23 mmol)을 DCM (60 mL)에 녹인 후, 아세트산무수물 (2.6 g, 25 mmol)을 서서히 적하하였다. 적하 완료 후 반응 용기를 알루미늄 호일을 이용하여 빛을 차단하고 4 시간 동안 실온에서 교반한다. 반응 종결을 TLC 로 확인한 후, 반응액에 증류수 (150 mL)와 DCM (100 mL)을 투입하였다. 수득된 유기층을 증류수 (150 mL)로 3 회 수세한 후, 감압 조건에서 농축하였다. 농축액은 극성 및 비극성 용매를 이용한 재결정 과정을 거쳐 노란색 고체 11.7 g을 91 % 수율로 획득하였다. The compound from Step 4 (12.0 g, 23 mmol) was dissolved in DCM (60 mL) under a nitrogen atmosphere, and then acetic anhydride (2.6 g, 25 mmol) was slowly added dropwise. After completion of the dropping, the reaction vessel is blocked from light using aluminum foil and stirred at room temperature for 4 hours. After confirming the completion of the reaction by TLC, distilled water (150 mL) and DCM (100 mL) were added to the reaction solution. The obtained organic layer was washed 3 times with distilled water (150 mL), and then concentrated under reduced pressure. The concentrate was recrystallized using polar and non-polar solvents to obtain 11.7 g of a yellow solid in 91% yield.

1H-NMR로 생성물을 확인하였다. 1 H-NMR confirmed the product.

1H-NMR (δ, ppm), CDCl3: 9.00 (s, 1H), 8.62 (s, 1H), 8.32 (d/d, 1H), 8.03 (d/d, 1H), 7.52-7.36 (m, 2H), 4.55 (t, 2H), 3.93 (t, 2H), 3.57-3.45 (m, 8H), 2.69 (t, 2H), 2.23 (s, 3H), 1.54 (m, 2H), 1.41-1.23 (m, 8H), 0.89 (t, 3H). 1 H-NMR (δ, ppm), CDCl 3 : 9.00 (s, 1H), 8.62 (s, 1H), 8.32 (d/d, 1H), 8.03 (d/d, 1H), 7.52-7.36 (m) , 2H), 4.55 (t, 2H), 3.93 (t, 2H), 3.57-3.45 (m, 8H), 2.69 (t, 2H), 2.23 (s, 3H), 1.54 (m, 2H), 1.41- 1.23 (m, 8H), 0.89 (t, 3H).

화학식 2-1 내지 2-8로 표현되는 α-케토옥심에스테르 카르바졸 유도체 화합물들은 상응하는 카르바졸 케톤화합물을 출발물질로 하여 실시예 2의 제조방법에 따라 하기 표 4와 같이 합성하였다.The α-ketooxime ester carbazole derivative compounds represented by Chemical Formulas 2-1 to 2-8 were synthesized as shown in Table 4 below according to the preparation method of Example 2 using the corresponding carbazole ketone compound as a starting material.

화학식 No.Formula No. R2 R 2 R3 R 3 1H-NMR (δ, ppm) 1 H-NMR (δ, ppm) 2-12-1 CH3 CH 3 CH3 CH 3 9.05 (s, 1H), 8.65 (s, 1H), 8.34 (d/d, 1H), 8.06 (d/d, 1H), 7.56-7.32 (m, 2H), 4.56 (t, 2H), 3.97 (t, 2H), 3.58 (t, 2H), 3.47 (t, 2H), 2.77 (s, 3H), 2.26 (s, 3H).9.05 (s, 1H), 8.65 (s, 1H), 8.34 (d/d, 1H), 8.06 (d/d, 1H), 7.56-7.32 (m, 2H), 4.56 (t, 2H), 3.97 ( t, 2H), 3.58 (t, 2H), 3.47 (t, 2H), 2.77 (s, 3H), 2.26 (s, 3H). 2-22-2 CH3 CH 3 C2H5 C 2 H 5 9.05 (s, 1H), 8.64 (s, 1H), 8.34 (d/d, 1H), 8.05 (d/d, 1H), 7.55-7.32 (m, 2H), 4.55 (t, 2H), 3.97 (t, 2H), 3.57 (t, 2H), 3.46 (t, 2H), 2.74 (q, 2H), 2.26 (s, 3H), 1.12 (t, 3H).9.05 (s, 1H), 8.64 (s, 1H), 8.34 (d/d, 1H), 8.05 (d/d, 1H), 7.55-7.32 (m, 2H), 4.55 (t, 2H), 3.97 ( t, 2H), 3.57 (t, 2H), 3.46 (t, 2H), 2.74 (q, 2H), 2.26 (s, 3H), 1.12 (t, 3H). 2-32-3 CH3 CH 3 C3H7 C 3 H 7 9.04 (s, 1H), 8.64 (s, 1H), 8.34 (d/d, 1H), 8.05 (d/d, 1H), 7.55-7.30 (m, 2H), 4.55 (t, 2H), 3.97 (t, 2H), 3.57 (t, 2H), 3.46 (t, 2H), 2.71 (t, 2H), 2.26 (s, 3H), 1.52 (m, 2H), 1.10 (t, 3H).9.04 (s, 1H), 8.64 (s, 1H), 8.34 (d/d, 1H), 8.05 (d/d, 1H), 7.55-7.30 (m, 2H), 4.55 (t, 2H), 3.97 ( t, 2H), 3.57 (t, 2H), 3.46 (t, 2H), 2.71 (t, 2H), 2.26 (s, 3H), 1.52 (m, 2H), 1.10 (t, 3H). 2-42-4 CH3 CH 3 C4H9 C 4 H 9 9.04 (s, 1H), 8.62 (s, 1H), 8.32 (d/d, 1H), 8.03 (d/d, 1H), 7.53-7.28 (m, 2H), 4.54 (t, 2H), 3.96 (t, 2H), 3.55 (t, 2H), 3.44 (t, 2H), 2.69 (t, 2H), 2.26 (s, 3H), 1.59-1.43 (m, 4H), 1.07 (t, 3H).9.04 (s, 1H), 8.62 (s, 1H), 8.32 (d/d, 1H), 8.03 (d/d, 1H), 7.53-7.28 (m, 2H), 4.54 (t, 2H), 3.96 ( t, 2H), 3.55 (t, 2H), 3.44 (t, 2H), 2.69 (t, 2H), 2.26 (s, 3H), 1.59-1.43 (m, 4H), 1.07 (t, 3H). 2-52-5 CH3 CH 3 C5H11 C 5 H 11 9.02 (s, 1H), 8.60 (s, 1H), 8.29 (d/d, 1H), 8.04 (d/d, 1H), 7.54-7.26 (m, 2H), 4.56 (t, 2H), 3.96 (t, 2H), 3.54 (t, 2H), 3.45 (t, 2H), 2.67 (t, 2H), 2.25 (s, 3H), 1.55-1.42 (m, 6H), 1.05 (t, 3H).9.02 (s, 1H), 8.60 (s, 1H), 8.29 (d/d, 1H), 8.04 (d/d, 1H), 7.54-7.26 (m, 2H), 4.56 (t, 2H), 3.96 ( t, 2H), 3.54 (t, 2H), 3.45 (t, 2H), 2.67 (t, 2H), 2.25 (s, 3H), 1.55-1.42 (m, 6H), 1.05 (t, 3H). 2-62-6 CH3 CH 3 C6H13 C 6 H 13 9.01 (s, 1H), 8.60 (s, 1H), 8.30 (d/d, 1H), 8.02 (d/d, 1H), 7.53-7.21 (m, 2H), 4.55 (t, 2H), 3.97 (t, 2H), 3.55 (t, 2H), 3.44 (t, 2H), 2.65 (t, 2H), 2.23 (s, 3H), 1.52-1.39 (m, 8H), 1.01 (t, 3H).9.01 (s, 1H), 8.60 (s, 1H), 8.30 (d/d, 1H), 8.02 (d/d, 1H), 7.53-7.21 (m, 2H), 4.55 (t, 2H), 3.97 ( t, 2H), 3.55 (t, 2H), 3.44 (t, 2H), 2.65 (t, 2H), 2.23 (s, 3H), 1.52-1.39 (m, 8H), 1.01 (t, 3H). 2-72-7 C6H5 C 6 H 5 C6H13 C 6 H 13 9.04 (s, 1H), 8.65 (s, 1H), 8.34 (d/d, 1H), 8.19 (d/d, 1H), 8.05 (d/d, 1H), 7.98 (d/d, 1H), 7.72-7.59 (m, 3H), 7.55-7.30 (m, 2H), 4.55 (t, 2H), 3.97 (t, 2H), 3.57 (t, 2H), 3.46 (t, 2H), 2.83 (t, 2H), 1.49-1.32 (m, 8H), 0.87 (t, 3H).9.04 (s, 1H), 8.65 (s, 1H), 8.34 (d/d, 1H), 8.19 (d/d, 1H), 8.05 (d/d, 1H), 7.98 (d/d, 1H), 7.72-7.59 (m, 3H), 7.55-7.30 (m, 2H), 4.55 (t, 2H), 3.97 (t, 2H), 3.57 (t, 2H), 3.46 (t, 2H), 2.83 (t, 2H), 1.49-1.32 (m, 8H), 0.87 (t, 3H). 2-82-8 CH3 CH 3 C7H7 C 7 H 7 9.04 (s, 1H), 8.62 (s, 1H), 8.38 (d/d, 1H), 8.02 (d/d, 1H), 7.63 (d, 1H), 7.53 (m, 2H), 7.49-7.22 (m, 3H), 4.56 (t, 2H), 3.94 (t, 2H), 3.57-3.42 (m, 12H), 2.40 (s, 3H), 2.28 (s, 3H). 9.04 (s, 1H), 8.62 (s, 1H), 8.38 (d/d, 1H), 8.02 (d/d, 1H), 7.63 (d, 1H), 7.53 (m, 2H), 7.49-7.22 ( m, 3H), 4.56 (t, 2H), 3.94 (t, 2H), 3.57-3.42 (m, 12H), 2.40 (s, 3H), 2.28 (s, 3H).

화학식 2-9 내지 2-13 그리고 2-15 및 2-16으로 표현되는α-케토옥심에스테르 카르바졸 유도체 화합물들은 실시예 2의 제조방법에 준하여 표 5와 같이 합성한다.The α-ketooxime ester carbazole derivative compounds represented by Formulas 2-9 to 2-13 and 2-15 and 2-16 were synthesized as shown in Table 5 according to the preparation method of Example 2.

화학식 No.Formula No. R2 R 2 R3 R 3 1H-NMR (δ, ppm) 1 H-NMR (δ, ppm) 2-92-9 CH3 CH 3 CH3 CH 3 9.03 (s, 1H), 8.62 (s, 1H), 8.34 (d/d, 1H), 8.05 (d/d, 1H), 7.54-7.31 (m, 2H), 4.56 (t, 2H), 3.91 (t, 2H), 3.58-3.43 (m, 8H), 2.72 (s, 3H), 2.26 (s, 3H).9.03 (s, 1H), 8.62 (s, 1H), 8.34 (d/d, 1H), 8.05 (d/d, 1H), 7.54-7.31 (m, 2H), 4.56 (t, 2H), 3.91 ( t, 2H), 3.58-3.43 (m, 8H), 2.72 (s, 3H), 2.26 (s, 3H). 2-102-10 CH3 CH 3 C2H5 C 2 H 5 9.04 (s, 1H), 8.61 (s, 1H), 8.34 (d/d, 1H), 8.04 (d/d, 1H), 7.55-7.30 (m, 2H), 4.56 (t, 2H), 3.92 (t, 2H), 3.57-3.44 (m, 8H), 2.71 (q, 2H), 2.25 (s, 3H), 1.11 (t, 3H).9.04 (s, 1H), 8.61 (s, 1H), 8.34 (d/d, 1H), 8.04 (d/d, 1H), 7.55-7.30 (m, 2H), 4.56 (t, 2H), 3.92 ( t, 2H), 3.57-3.44 (m, 8H), 2.71 (q, 2H), 2.25 (s, 3H), 1.11 (t, 3H). 2-112-11 CH3 CH 3 C3H7 C 3 H 7 9.03 (s, 1H), 8.61 (s, 1H), 8.32 (d/d, 1H), 8.03 (d/d, 1H), 7.55-7.28 (m, 2H), 4.56 (t, 2H), 3.90 (t, 2H), 3.58-3.43 (m, 8H), 2.69 (t, 2H), 2.25 (s, 3H), 1.69 (m, 2H), 1.09 (t, 3H).9.03 (s, 1H), 8.61 (s, 1H), 8.32 (d/d, 1H), 8.03 (d/d, 1H), 7.55-7.28 (m, 2H), 4.56 (t, 2H), 3.90 ( t, 2H), 3.58-3.43 (m, 8H), 2.69 (t, 2H), 2.25 (s, 3H), 1.69 (m, 2H), 1.09 (t, 3H). 2-122-12 CH3 CH 3 C4H9 C 4 H 9 9.03 (s, 1H), 8.62 (s, 1H), 8.32 (d/d, 1H), 8.02 (d/d, 1H), 7.53-7.28 (m, 2H), 4.56 (t, 2H), 3.92 (t, 2H), 3.56-3.42 (m, 8H), 2.67 (t, 2H), 2.24 (s, 3H), 1.57-1.43 (m, 4H), 1.06 (t, 3H).9.03 (s, 1H), 8.62 (s, 1H), 8.32 (d/d, 1H), 8.02 (d/d, 1H), 7.53-7.28 (m, 2H), 4.56 (t, 2H), 3.92 ( t, 2H), 3.56-3.42 (m, 8H), 2.67 (t, 2H), 2.24 (s, 3H), 1.57-1.43 (m, 4H), 1.06 (t, 3H). 2-132-13 CH3 CH 3 C5H11 C 5 H 11 9.02 (s, 1H), 8.59 (s, 1H), 8.29 (d/d, 1H), 8.01 (d/d, 1H), 7.55-7.26 (m, 2H), 4.55 (t, 2H), 3.93 (t, 2H), 3.56-3.43 (m, 8H), 2.65 (t, 2H), 2.23 (s, 3H), 1.65-1.44 (m, 6H), 1.05 (t, 3H).9.02 (s, 1H), 8.59 (s, 1H), 8.29 (d/d, 1H), 8.01 (d/d, 1H), 7.55-7.26 (m, 2H), 4.55 (t, 2H), 3.93 ( t, 2H), 3.56-3.43 (m, 8H), 2.65 (t, 2H), 2.23 (s, 3H), 1.65-1.44 (m, 6H), 1.05 (t, 3H). 2-152-15 C6H5 C 6 H 5 C6H13 C 6 H 13 9.04 (s, 1H), 8.65 (s, 1H), 8.34 (d/d, 1H), 8.19 (d/d, 1H), 8.05 (d/d, 1H), 7.98 (d/d, 1H), 7.72-7.59 (m, 3H), 7.55-7.30 (m, 2H), 4.54 (t, 2H), 3.94 (t, 2H), 3.59-3.46 (m, 8H), 2.83 (t, 2H), 1.49-1.32 (m, 8H), 0.87 (t, 3H).9.04 (s, 1H), 8.65 (s, 1H), 8.34 (d/d, 1H), 8.19 (d/d, 1H), 8.05 (d/d, 1H), 7.98 (d/d, 1H), 7.72-7.59 (m, 3H), 7.55-7.30 (m, 2H), 4.54 (t, 2H), 3.94 (t, 2H), 3.59-3.46 (m, 8H), 2.83 (t, 2H), 1.49- 1.32 (m, 8H), 0.87 (t, 3H). 2-162-16 CH3 CH 3 C7H7 C 7 H 7 9.04 (s, 1H), 8.62 (s, 1H), 8.38 (d/d, 1H), 8.02 (d/d, 1H), 7.63 (d, 1H), 7.53 (m, 2H), 7.49-7.22 (m, 3H), 4.57 (t, 2H), 3.94 (t, 2H), 3.59-3.44 (m, 8H), 2.40 (s, 3H), 2.28 (s, 3H). 9.04 (s, 1H), 8.62 (s, 1H), 8.38 (d/d, 1H), 8.02 (d/d, 1H), 7.63 (d, 1H), 7.53 (m, 2H), 7.49-7.22 ( m, 3H), 4.57 (t, 2H), 3.94 (t, 2H), 3.59-3.44 (m, 8H), 2.40 (s, 3H), 2.28 (s, 3H).

화학식 2-17 내지 2-24로 표현되는 α-케토옥심에스테르 카르바졸 유도체 화합물들은 상응하는 카르바졸 케톤화합물을 출발물질로 하여 실시예 2의 제조방법에 따라 하기 표 6과 같이 합성하였다.The α-ketooxime ester carbazole derivative compounds represented by Formulas 2-17 to 2-24 were synthesized as shown in Table 6 below according to the preparation method of Example 2 using the corresponding carbazole ketone compound as a starting material.

화학식 No.Formula No. R2 R 2 R3 R 3 1H-NMR (δ, ppm) 1 H-NMR (δ, ppm) 2-172-17 CH3 CH 3 CH3 CH 3 9.04 (s, 1H), 8.64 (s, 1H), 8.34 (d/d, 1H), 8.06 (d/d, 1H), 7.56-7.32 (m, 2H), 4.57 (t, 2H), 3.93 (t, 2H), 3.61-3.49 (m, 12H), 2.72 (t, 2H), 2.26 (s, 3H).9.04 (s, 1H), 8.64 (s, 1H), 8.34 (d/d, 1H), 8.06 (d/d, 1H), 7.56-7.32 (m, 2H), 4.57 (t, 2H), 3.93 ( t, 2H), 3.61-3.49 (m, 12H), 2.72 (t, 2H), 2.26 (s, 3H). 2-182-18 CH3 CH 3 C2H5 C 2 H 5 9.04 (s, 1H), 8.63 (s, 1H), 8.34 (d/d, 1H), 8.05 (d/d, 1H), 7.55-7.32 (m, 2H), 4.57 (t, 2H), 3.93 (t, 2H), 3.61-3.50 (m, 12H), 2.71 (q, 2H), 2.25 (s, 3H), 1.12 (t, 3H).9.04 (s, 1H), 8.63 (s, 1H), 8.34 (d/d, 1H), 8.05 (d/d, 1H), 7.55-7.32 (m, 2H), 4.57 (t, 2H), 3.93 ( t, 2H), 3.61-3.50 (m, 12H), 2.71 (q, 2H), 2.25 (s, 3H), 1.12 (t, 3H). 2-192-19 CH3 CH 3 C3H7 C 3 H 7 9.03 (s, 1H), 8.63 (s, 1H), 8.32 (d/d, 1H), 8.05 (d/d, 1H), 7.55-7.30 (m, 2H), 4.57 (t, 2H), 3.93 (t, 2H), 3.60-3.48 (m, 12H), 2.70 (t, 2H), 2.25 (s, 3H), 1.09 (t, 3H).9.03 (s, 1H), 8.63 (s, 1H), 8.32 (d/d, 1H), 8.05 (d/d, 1H), 7.55-7.30 (m, 2H), 4.57 (t, 2H), 3.93 ( t, 2H), 3.60-3.48 (m, 12H), 2.70 (t, 2H), 2.25 (s, 3H), 1.09 (t, 3H). 2-202-20 CH3 CH 3 C4H9 C 4 H 9 9.04 (s, 1H), 8.62 (s, 1H), 8.32 (d/d, 1H), 8.03 (d/d, 1H), 7.53-7.28 (m, 2H), 4.56 (t, 2H), 3.94 (t, 2H), 3.59-3.45 (m, 12H), 2.69 (t, 2H), 2.24 (s, 3H), 1.58-1.43 (m, 4H), 1.07 (t, 3H).9.04 (s, 1H), 8.62 (s, 1H), 8.32 (d/d, 1H), 8.03 (d/d, 1H), 7.53-7.28 (m, 2H), 4.56 (t, 2H), 3.94 ( t, 2H), 3.59-3.45 (m, 12H), 2.69 (t, 2H), 2.24 (s, 3H), 1.58-1.43 (m, 4H), 1.07 (t, 3H). 2-212-21 CH3 CH 3 C5H11 C 5 H 11 9.02 (s, 1H), 8.60 (s, 1H), 8.29 (d/d, 1H), 8.04 (d/d, 1H), 7.54-7.26 (m, 2H), 4.56 (t, 2H), 3.93 (t, 2H), 3.60-3.45 (m, 12H), 2.67 (t, 2H), 2.25 (s, 3H), 1.55-1.42 (m, 6H), 1.05 (t, 3H).9.02 (s, 1H), 8.60 (s, 1H), 8.29 (d/d, 1H), 8.04 (d/d, 1H), 7.54-7.26 (m, 2H), 4.56 (t, 2H), 3.93 ( t, 2H), 3.60-3.45 (m, 12H), 2.67 (t, 2H), 2.25 (s, 3H), 1.55-1.42 (m, 6H), 1.05 (t, 3H). 2-222-22 CH3 CH 3 C6H13 C 6 H 13 9.00 (s, 1H), 8.62 (s, 1H), 8.32 (d/d, 1H), 8.03 (d/d, 1H), 7.52-7.36 (m, 2H), 4.55 (t, 2H), 3.92 (t, 2H), 3.60-3.42 (m, 12H), 2.69 (t, 2H), 2.23 (s, 3H), 1.54 (m, 2H), 1.41-1.23 (m, 8H), 0.89 (t, 3H).9.00 (s, 1H), 8.62 (s, 1H), 8.32 (d/d, 1H), 8.03 (d/d, 1H), 7.52-7.36 (m, 2H), 4.55 (t, 2H), 3.92 ( t, 2H), 3.60-3.42 (m, 12H), 2.69 (t, 2H), 2.23 (s, 3H), 1.54 (m, 2H), 1.41-1.23 (m, 8H), 0.89 (t, 3H) . 2-232-23 C6H5 C 6 H 5 C6H13 C 6 H 13 9.03 (s, 1H), 8.64 (s, 1H), 8.34 (d/d, 1H), 8.19 (d/d, 1H), 8.05 (d/d, 1H), 7.98 (d/d, 1H), 7.72-7.59 (m, 3H), 7.55-7.30 (m, 2H), 4.56 (t, 2H), 3.91 (t, 2H), 3.62-3.45 (m, 12H), 2.83 (t, 2H), 1.49-1.32 (m, 8H), 0.87 (t, 3H).9.03 (s, 1H), 8.64 (s, 1H), 8.34 (d/d, 1H), 8.19 (d/d, 1H), 8.05 (d/d, 1H), 7.98 (d/d, 1H), 7.72-7.59 (m, 3H), 7.55-7.30 (m, 2H), 4.56 (t, 2H), 3.91 (t, 2H), 3.62-3.45 (m, 12H), 2.83 (t, 2H), 1.49- 1.32 (m, 8H), 0.87 (t, 3H). 2-242-24 CH3 CH 3 C7H7 C 7 H 7 9.04 (s, 1H), 8.62 (s, 1H), 8.38 (d/d, 1H), 8.02 (d/d, 1H), 7.63 (d, 1H), 7.53 (m, 2H), 7.49-7.22 (m, 3H), 4.55 (t, 2H), 3.91 (t, 2H), 3.58-3.44 (m, 12H), 2.40 (s, 3H), 2.28 (s, 3H). 9.04 (s, 1H), 8.62 (s, 1H), 8.38 (d/d, 1H), 8.02 (d/d, 1H), 7.63 (d, 1H), 7.53 (m, 2H), 7.49-7.22 ( m, 3H), 4.55 (t, 2H), 3.91 (t, 2H), 3.58-3.44 (m, 12H), 2.40 (s, 3H), 2.28 (s, 3H).

<제조예 > 감광성 수지 조성물 제조<Preparation Example> Preparation of photosensitive resin composition

교반기가 설치되어 있는 반응 혼합조에 하기 표 7에 기재된 성분과 함량에 따라 프로필렌글리콜메틸에테르아세테이트(PGMEA; Propylene Glycol Methyl Ether Acetate) 용매, 폴리히드록시스티렌수지(PHS), 디펜타에리트리톨헥사아 크릴레이트(DPHA, Aldrich), 실시예에 따른 광개시제를 순차적으로 첨가하고, 상온에서 교반하여 감광성 수지 조성물을 제조하였다.Propylene glycol methyl ether acetate (PGMEA; Propylene Glycol Methyl Ether Acetate) solvent, polyhydroxystyrene resin (PHS), dipentaerythritol hexaacrylic A photosensitive resin composition was prepared by sequentially adding the rate (DPHA, Aldrich) and the photoinitiator according to the examples, and stirring at room temperature.

[화학식 3][Formula 3]

Figure pat00021
Figure pat00021

PHS : 알드리치사 (폴리 4-히드록시페놀), Mw=25,000PHS: Aldrich (poly 4-hydroxyphenol), Mw=25,000

[화학식 4][Formula 4]

Figure pat00022
Figure pat00022

DPHA : 알드리치사, 디펜타에리트리톨헥사아크릴레이트DPHA: Aldrich, dipentaerythritol hexaacrylate

감광성 수지 조성물의 감도를 비교하기 위하여 하기 화학식 5 내지 8로 표시되는 화합물을 혼합하여 비교예 1 내지 4의 시료를 준비하였다. In order to compare the sensitivity of the photosensitive resin composition, the samples of Comparative Examples 1 to 4 were prepared by mixing the compounds represented by the following Chemical Formulas 5 to 8.

[화학식 5][Formula 5]

Figure pat00023
Figure pat00023

상기 화학식 5로 표시되는 화합물을 상기 실시예 1에서 합성된 케톤 화합물에서 니트로화(nitration)를 배제하고, 옥심 반응과 아세틸레이션을 통하여 제조하였다. The compound represented by Formula 5 was prepared through an oxime reaction and acetylation, excluding nitration from the ketone compound synthesized in Example 1.

[화학식 6][Formula 6]

Figure pat00024
Figure pat00024

상기 화학식 6으로 표시되는 화합물을 실시예 2에서 합성된 케톤 화합물에서 니트로화를 배제하고, 옥심 반응과 아세틸레이션을 통하여 제조하였다. The compound represented by Formula 6 was prepared through oxime reaction and acetylation, excluding nitration from the ketone compound synthesized in Example 2.

[화학식 7][Formula 7]

Figure pat00025
Figure pat00025

상기 화학식 7로 표시되는 화합물은 BASF사의 OXE-01이다. The compound represented by Formula 7 is OXE-01 manufactured by BASF.

[화학식 8][Formula 8]

Figure pat00026
Figure pat00026

상기 화학식 8로 표시되는 화합물은 BASF사의 OXE-02이다.The compound represented by Formula 8 is OXE-02 manufactured by BASF.

광개시제(g)Photoinitiator (g) PHS(g)PHS(g) DPHA(g)DPHA(g) PGMEA(g)PGMEA(g) 화학식 1-11 (1) Formula 1-11 (1) 2020 1010 6969 화학식 1-13 (1)Formula 1-13 (1) 2020 1010 6969 화학식 1-15 (1)Formula 1-15 (1) 2020 1010 6969 화학식 1-17 (1)Formula 1-17 (1) 2020 1010 6969 화학식 1-19 (1)Formula 1-19 (1) 2020 1010 6969 화학식 1-20 (1)Formula 1-20 (1) 2020 1010 6969 화학식 2-12 (1)Formula 2-12 (1) 2020 1010 6969 화학식 2-14 (1)Formula 2-14 (1) 2020 1010 6969 화학식 2-15 (1)Formula 2-15 (1) 2020 1010 6969 화학식 2-16 (1)Formula 2-16 (1) 2020 1010 6969 비교예 1 (화학식 5) (1)Comparative Example 1 (Formula 5) (1) 2020 1010 6969 비교예 2 (화학식 6) (1)Comparative Example 2 (Formula 6) (1) 2020 1010 6969 비교예 3 (화학식 7) (1)Comparative Example 3 (Formula 7) (1) 2020 1010 6969 비교예 4 (화학식 8) (1)Comparative Example 4 (Formula 8) (1) 2020 1010 6969

<실험예> 감광성 수지 조성물의 감도 평가<Experimental Example> Sensitivity evaluation of the photosensitive resin composition

상기 제조된 옥심에스테르계 광개시제와 α-케토옥심에스테르계 광개시제 및 비교예 1 내지 4에서 제조한 감광성 수지 조성물 광감도를 평가하였다. The photosensitivity of the oxime ester-based photoinitiator prepared above, the α-ketooxime ester-based photoinitiator and the photosensitive resin composition prepared in Comparative Examples 1 to 4 was evaluated.

유리기판 위에 건조 후 막 두께가 5 um이 되도록 코팅하고, 120 ℃에서 2 분간 110 ℃에서 90 초간 건조하여 용제를 휘발시킨다. After drying on a glass substrate, it is coated to a film thickness of 5 μm, and dried at 120° C. for 2 minutes at 110° C. for 90 seconds to volatilize the solvent.

퓨전램프로 노광하고 23 ℃에서 0.45 % KOH 수용액에 현상한 후 두께를 비접촉식 두께 측정기를 이용하여 초기 두께 대비 80 %를 유지하는 노광량을 기준으로 감도를 측정하였다. After exposure with a fusion lamp and development in 0.45% KOH aqueous solution at 23°C, the thickness was measured using a non-contact thickness measuring device based on the exposure amount maintaining 80% of the initial thickness.

여기서 노광량 수치가 낮을수록 감도가 우수한 것을 의미한다.Here, the lower the exposure value, the better the sensitivity.

감도
(mJ/cm2)
Sensitivity
(mJ/cm 2 )
화학식 1-11Formula 1-11 3030 화학식 1-13Formula 1-13 3030 화학식 1-15Formula 1-15 3030 화학식 1-17Formula 1-17 3030 화학식 1-19Formula 1-19 3030 화학식 1-20Formula 1-20 3535 화학식 2-12Formula 2-12 2525 화학식 2-14Formula 2-14 2525 화학식 2-15Formula 2-15 3030 화학식 2-16Formula 2-16 2525 비교예 1 (화학식 3)Comparative Example 1 (Formula 3) 100100 비교예 2 (화학식 4)Comparative Example 2 (Formula 4) 8080 비교예 3 (OXE-01)Comparative Example 3 (OXE-01) 8080 비교예 4 (OXE-02)Comparative Example 4 (OXE-02) 6060

감도 측정결과를 도 1 및 표 8에 나타내었다. The sensitivity measurement results are shown in FIG. 1 and Table 8.

도 1 및 표 8을 참조하면, 본 발명의 실시예에 따른 감광성 수지 조성물의 고감도인 것을 확인하였으며, 특히 비교예 1 및 2와 비교하여 니트로기로 치환되는 경우 감도가 매우 증가되는 것을 확인하였다. 1 and Table 8, it was confirmed that the high sensitivity of the photosensitive resin composition according to the embodiment of the present invention, in particular, compared to Comparative Examples 1 and 2, when substituted with a nitro group, it was confirmed that the sensitivity is greatly increased.

상용 광개시제(비교예 3 및 4)에 대비 고감도이므로, 포토 레지스트 공정 등의 효율을 증가시킬 수 있다. Since it is highly sensitive compared to commercial photoinitiators (Comparative Examples 3 and 4), it is possible to increase the efficiency of the photoresist process and the like.

이상에서 설명한 바와 같이, 본 발명의 구성 및 작용을 본 발명에 따른 바람직한 실시예를 기초로 설명하였으나, 본 발명은 특정 실시예에 한정되는 것은 아니며, 해당분야 통상의 지식을 갖는 자라면 후술될 특허청구범위에 기재된 본 발명의 사상 및 기술 영역으로부터 벗어나지 않는 범위 내에서 본 발명을 다양하게 수정 및 변경시킬 수 있다.As described above, the configuration and operation of the present invention has been described based on a preferred embodiment according to the present invention, but the present invention is not limited to a specific embodiment, and those of ordinary skill in the art will use a patent to be described later. Various modifications and changes can be made to the present invention without departing from the spirit and scope of the present invention described in the claims.

Claims (7)

하기 화학식 1 또는 화학식 2로 표시되는 옥심에스테르 카르바졸 화합물:
[화학식 1]
Figure pat00027


[화학식 2]
Figure pat00028


여기서, X는 Cl 또는 Br이고, R1 과 R3 는 각각 독립적으로 C1 내지 C20 알킬, C5 내지 C10 시클로알킬, C6 내지 C30 아릴옥시, C1 내지 C20 알킬티오, C6 내지 C30 아릴, C7 내지 C30 아르알킬, 또는 C5 내지 C30 헤테로아릴이며, R2 는 C1 내지 C3 알킬 또는 페닐이고,
n은 1 내지 3의 정수임.
An oxime ester carbazole compound represented by the following Chemical Formula 1 or Chemical Formula 2:
[Formula 1]
Figure pat00027


[Formula 2]
Figure pat00028


wherein X is Cl or Br, R 1 and R 3 are each independently C 1 to C 20 alkyl, C 5 to C 10 cycloalkyl, C 6 to C 30 aryloxy, C 1 to C 20 alkylthio, C 6 to C 30 aryl, C 7 to C 30 aralkyl, or C 5 to C 30 heteroaryl, R 2 is C 1 to C 3 alkyl or phenyl;
n is an integer from 1 to 3.
제1항에 있어서, X는 Cl이고, R1 과 R3 는 각각 독립적으로 직쇄 또는 분기쇄인 C1 내지 C20 알킬, C5 내지 C10 시클로알킬, C6 내지 C30 아릴이고, R2 는 메틸 또는 페닐인 것을 특징으로 하는 옥심에스테르 카르바졸 화합물.
The method according to claim 1, wherein X is Cl, R 1 and R 3 are each independently linear or branched C 1 to C 20 alkyl, C 5 to C 10 cycloalkyl, C 6 to C 30 aryl, and R 2 is methyl or phenyl oxime ester carbazole compound.
제1항에 있어서, 상기 화학식 1의 화합물은 하기 화학식 1-1 내지 1-30 중 선택되는 어느 하나인 것을 특징으로 하는 옥심에스테르 카르바졸 화합물:
Figure pat00029

Figure pat00030

Figure pat00031






The oxime ester carbazole compound according to claim 1, wherein the compound of Formula 1 is any one selected from the following Formulas 1-1 to 1-30:
Figure pat00029

Figure pat00030

Figure pat00031






제1항에 있어서, 상기 화학식 2의 화합물은 하기 화학식 2-1 내지 2-24 중 선택되는 어느 하나인 것을 특징으로 하는 옥심에스테르 카르바졸 화합물:
Figure pat00032

Figure pat00033

Figure pat00034

The oxime ester carbazole compound according to claim 1, wherein the compound of Formula 2 is any one selected from the following Formulas 2-1 to 2-24:
Figure pat00032

Figure pat00033

Figure pat00034

제1항 내지 제5항 중 어느 한 항의 옥심에스테르 카르바졸 화합물; 및 에틸렌계 불포화 결합을 가지는 화합물을 포함하는 감광성 수지 조성물.
The oxime ester carbazole compound of any one of Claims 1-5; and a compound having an ethylenically unsaturated bond.
제5항에 있어서, 현상성 바인더 수지를 더 포함하는 감광성 수지 조성물.
The photosensitive resin composition according to claim 5, further comprising a developable binder resin.
제6항에 있어서, 상기 현상성 바인더 수지는 아크릴산함유 아크릴공중합체, 노볼락계 페놀수지, 폴리히드록시스트렌수지, 폴리실록산수지, 폴리이미드수지, 히드록시스티렌 및 아크릴레이트의 공중합체로 이루어진 군에서 선택된 어느 하나 또는 둘 이상의 혼합물인 것을 특징으로 하는 감광성 수지 조성물.

7. The group of claim 6, wherein the developable binder resin is an acrylic acid-containing acrylic copolymer, a novolak-based phenol resin, a polyhydroxystyrene resin, a polysiloxane resin, a polyimide resin, a hydroxystyrene, and a copolymer of acrylate. Photosensitive resin composition, characterized in that any one or a mixture of two or more selected from.

KR1020200068963A 2020-06-08 2020-06-08 Oxime ester carbazole compound,and photosensitive resin composition containing thereof KR102397593B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020200068963A KR102397593B1 (en) 2020-06-08 2020-06-08 Oxime ester carbazole compound,and photosensitive resin composition containing thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020200068963A KR102397593B1 (en) 2020-06-08 2020-06-08 Oxime ester carbazole compound,and photosensitive resin composition containing thereof

Publications (2)

Publication Number Publication Date
KR20210152189A true KR20210152189A (en) 2021-12-15
KR102397593B1 KR102397593B1 (en) 2022-05-16

Family

ID=78865800

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200068963A KR102397593B1 (en) 2020-06-08 2020-06-08 Oxime ester carbazole compound,and photosensitive resin composition containing thereof

Country Status (1)

Country Link
KR (1) KR102397593B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115124453A (en) * 2022-07-13 2022-09-30 深圳市芯研材料科技有限公司 Nitrocarbazole oxime ester photoinitiator for improving solubility by group modification and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090009991A (en) * 2006-12-27 2009-01-23 가부시키가이샤 아데카 Oxime ester compound and photopolymerization initiator containing the compound
JP2010215575A (en) * 2009-03-18 2010-09-30 Toyo Ink Mfg Co Ltd New oxime ester compound, radical polymerization initiator containing the same, polymerizable composition, negative type resist by using the same and method for forming image pattern by using the same
KR20180063650A (en) * 2016-12-02 2018-06-12 삼성에스디아이 주식회사 Photosensitive resin composition, black pixel defining layer using the same and display device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090009991A (en) * 2006-12-27 2009-01-23 가부시키가이샤 아데카 Oxime ester compound and photopolymerization initiator containing the compound
JP2010215575A (en) * 2009-03-18 2010-09-30 Toyo Ink Mfg Co Ltd New oxime ester compound, radical polymerization initiator containing the same, polymerizable composition, negative type resist by using the same and method for forming image pattern by using the same
KR20180063650A (en) * 2016-12-02 2018-06-12 삼성에스디아이 주식회사 Photosensitive resin composition, black pixel defining layer using the same and display device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115124453A (en) * 2022-07-13 2022-09-30 深圳市芯研材料科技有限公司 Nitrocarbazole oxime ester photoinitiator for improving solubility by group modification and preparation method thereof

Also Published As

Publication number Publication date
KR102397593B1 (en) 2022-05-16

Similar Documents

Publication Publication Date Title
KR101518774B1 (en) Novel fluorene oxime ester compounds, photopolymerization initiator and photoresist composition containing the same
JP6196363B2 (en) Novel β-oxime ester fluorene compound, photopolymerization initiator containing the same, and photoresist composition
EP2397903B1 (en) Photoactive compound and photosensitive resin composition containing the same
JP4914972B2 (en) Oxime ester compound, method for producing oxime ester compound, photopolymerization initiator, and photosensitive composition
WO2013018978A1 (en) Photoactive compound and a light-sensitive resin composition comprising same
TW201634444A (en) Oxime ester compounds, photopolymerization initiator and photopolymerizable composition containing the same, molded article and display device
KR20180026347A (en) Colored composition and compound
WO2016058551A1 (en) Photosensitive resin composition, method for manufacturing colour filter, colour filter and liquid crystal display device
KR102397593B1 (en) Oxime ester carbazole compound,and photosensitive resin composition containing thereof
CN110066352B (en) Oxime ester photoinitiator, preparation method, photosensitive resin composition and application
KR101574535B1 (en) Novel biphenyl oxime ester compounds, photoinitiator and photoresist composition containing the same
KR20210111690A (en) Novel oxime ester carbazole dereivative compounds
KR101824429B1 (en) Novel di-oxime ester compounds and photopolymerization initiator and photoresist composition containing the same
KR20090107977A (en) Photoactive compound, and photosensitive resin composition comprising the same
KR101478292B1 (en) Novel biphenyl β-oxime ester compounds, photoinitiator and photoresist composition containing the same
KR101546103B1 (en) Photoactive compound containing a silyl group and photosensitive resin composition comprising the same
KR102541140B1 (en) Novel oxime ester carbazole dereivative compounds
KR101991838B1 (en) Novel 1,3-benzodiazole beta-oxime ester compound and composition comprising the same
KR101623624B1 (en) Photoactive compound, photosensitive resin composition comprising the photoactive compound, photosensitive material manufactured by using the photosensitive resin composition and display device having the photosensitive material
KR20200136559A (en) Highly photosensitive oxime ester based photoinitiator and photosensitive compositions including the same
KR101777845B1 (en) Novel fluoranthene oxime ester derivates, photopolymerization initiator and photoresist composition containing the same
CN115704994A (en) Photosensitive resin composition, use thereof, display device, and semiconductor device
KR20200028710A (en) New β-oxime ester biphenyl compounds, photoinitiators containing them and photosensitive resin compositions
TW202402731A (en) Amino-group-containing polyfunctional (meth)acrylate composition and method for producting amino-group-containing polyfunctional (meth)acrylate
KR20170050618A (en) Novel quinolinyl beta oxime ester derivative compound, photopolymerization initiator, and photoresist composition containing the same

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant